U.S. patent application number 09/735125 was filed with the patent office on 2001-07-26 for method for disinfecting body fluids.
Invention is credited to Messier, Pierre Jean.
Application Number | 20010009661 09/735125 |
Document ID | / |
Family ID | 26725146 |
Filed Date | 2001-07-26 |
United States Patent
Application |
20010009661 |
Kind Code |
A1 |
Messier, Pierre Jean |
July 26, 2001 |
Method for disinfecting body fluids
Abstract
The present invention relates to iodine demand disinfectants. It
relates in particular to a process for preparing a polyiodide-resin
for use as an iodine demand disinfectant wherein a porous strong
base anion exchange resin in a salt form, is contacted with a
material capable of donating a member absorbable by the resin so as
to convert the resin to the polyiodide-resin. The adsorbable member
is selected from the group comprising I.sub.2 and polyiodide ion
having a valence of -1. The process is characterized in that
conversion of the anion exchange resin to the polyiodide-resin is
effected at elevated temperature and elevated pressure, the
elevated temperature being 100 degrees C. or higher, the elevated
pressure being greater than atmospheric pressure. The present
invention also relates to disinfectant substance comprising an
iodine (impregnated) resin as produced by the above process.
Inventors: |
Messier, Pierre Jean;
(Mirabel, CA) |
Correspondence
Address: |
Timothy E. Nauman
Fay, Sharpe, Beall, Fagan, Minnich & McKee
Suite 700
1100 Superior Avenue
Cleveland
OH
44114-2518
US
|
Family ID: |
26725146 |
Appl. No.: |
09/735125 |
Filed: |
February 15, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
09735125 |
Feb 15, 2001 |
|
|
|
09465968 |
Dec 14, 1999 |
|
|
|
09465968 |
Dec 14, 1999 |
|
|
|
08803869 |
Feb 24, 1997 |
|
|
|
6045820 |
|
|
|
|
08803869 |
Feb 24, 1997 |
|
|
|
08256425 |
Jul 12, 1994 |
|
|
|
5639452 |
|
|
|
|
08256425 |
Jul 12, 1994 |
|
|
|
PCT/CA93/00378 |
Sep 15, 1993 |
|
|
|
PCT/CA93/00378 |
Sep 15, 1993 |
|
|
|
08047535 |
Apr 19, 1993 |
|
|
|
08047535 |
Apr 19, 1993 |
|
|
|
07957307 |
Sep 16, 1992 |
|
|
|
Current U.S.
Class: |
424/78.1 ;
424/405; 521/30 |
Current CPC
Class: |
A61L 26/0085 20130101;
A61L 9/00 20130101; A61L 9/12 20130101; A61L 2/16 20130101; A61L
2300/106 20130101; F24F 8/50 20210101; A61P 31/12 20180101; C02F
1/50 20130101; A61L 15/425 20130101; A61L 2300/404 20130101; A61L
26/0066 20130101; A61L 15/46 20130101; Y02A 50/20 20180101; A61P
31/04 20180101; A01N 59/12 20130101; A61L 2/23 20130101 |
Class at
Publication: |
424/78.1 ;
521/30; 424/405 |
International
Class: |
A61K 031/74; A01N
025/00 |
Claims
I claim:
1. A process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form with a sufficient amount of an
iodine-substance absorbable by the anion exchange resin such that
the anion exchange resin absorbs said iodine-substance so as to
convert the anion exchange resin to the demand disinfectant resin,
said iodine-substance being selected from the group comprising
I.sub.2 and polyiodide ions having a valence of -1, characterized
in that for the conversion step at least a portion of the
absorption of iodine-substance is effected at elevated temperature
and at elevated pressure, said elevated temperature being higher
than 100.degree. C., said elevated pressure being greater than
atmospheric pressure.
2. A process as defined in claim 1 wherein said elevated pressure
is a pressure of 2 psig or greater.
3. A process as defined in claim 1 wherein said elevated pressure
is a pressure of 5 psig or greater.
4. A process as defined in claim 3 wherein said elevated pressure
is a pressure of up to 100 psig.
5. A process as defined in claim 1 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
6. A process as defined in claim 1 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
7. A process as defined in claim 1 wherein said elevated
temperature is a temperature of 102.degree. C. or higher.
8. A process as defined in claim 1 wherein said elevated
temperature is a temperature of 115.degree. C. or higher.
9. A process as defined in claim 1 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
10. A process as defined in claim 1 wherein said elevated
temperature is a temperature of 102.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
11. A process as defined in claim 10 wherein said elevated
temperature is a temperature of up to 210.degree. C.
12. A process as defined in claim 1 wherein said elevated
temperature is a temperature of 110.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
13. A process as defined in claim 12 wherein said elevated
temperature is a temperature of up to 150.degree. C.
14. A process as defined in claim 12 wherein said elevated
temperature is of from 115.degree. C. to 135.degree. C.
15. A process as defined in claim 1 wherein said elevated
temperature is a temperature of 115.degree. C. or higher and said
elevated pressure is a pressure of from 5 to 35 psig.
16. A process as defined in claim 15 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
17. A process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form other than the iodide form I.sup.-, with a
sufficient amount of an iodine-substance absorbable by the anion
exchange resin such that the anion exchange resin absorbs said
iodine-substance so as to convert the anion exchange resin to the
demand disinfectant resin, said iodine-substance being selected
from the group comprising polyiodide ions having a valence of -1,
characterized in that for the conversion step at least a portion of
the absorption of iodine-substance is effected at elevated
temperature and at elevated pressure, said elevated temperature
being 100.degree. C. or higher, said elevated pressure being
greater than atmospheric pressure.
18. A process as defined in claim 17 wherein said iodine-substance
comprises triiodide ions of formula I.sub.3.sup.-.
19. A process as defined in claim 17 wherein the anion exchange
resin is in the chloride form Cl.sup.-.
20. A process as defined in claim 17 wherein the anion exchange
resin is in the hydroxyl form OH.sup.-.
21. A process as defined in claim 17 wherein said elevated pressure
is a pressure of 2 psig or greater.
22. A process as defined in claim 17 wherein said elevated pressure
is a pressure of 5 psig or greater.
23. A process as defined in claim 22 wherein said elevated pressure
is a pressure of up to 100 psig.
24. A process as defined in claim 18 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
25. A process as defined in claim 18 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
26. A process as defined in claim 18 wherein said elevated
temperature is a temperature of 102.degree. C. or higher.
27. A process as defined in claim 18 wherein said elevated
temperature is a temperature of 115.degree. C. or higher.
28. A process as defined in claim 18 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
29. A process as defined in claim 18 wherein said elevated
temperature is a temperature of 102.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
30. A process as defined in claim 29 wherein said elevated
temperature is a temperature of up to 210.degree. C.
31. A process as defined in claim 29 wherein the anion exchange
resin is in the chloride form Cl.sup.-.
32. A process as defined in claim 29 wherein the anion exchange
resin is in the hydroxyl form OH.sup.-.
33. A process as defined in claim 18 wherein said elevated
temperature is a temperature of 110.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
34. A process as defined in claim 33 wherein said elevated
temperature is a temperature of up to 150.degree. C.
35. A process as defined in claim 33 wherein said elevated
temperature is of from 115.degree. C. to 135.degree. C.
36. A process as defined in claim 18 wherein said elevated
temperature is a temperature of 115.degree. C. or higher and said
elevated pressure is a pressure of from 5 to 35 psig.
37. A process as defined in claim 36 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
38. A process as defined in claim 37 wherein the anion exchange
resin is in the chloride form Cl.sup.-.
39. A process as defined in claim 37 wherein the anion exchange
resin is in the hydroxyl form OH.sup.-.
40. A process as defined in claim 18 wherein the anion exchange
resin is a quaternary ammonium anion exchange resin.
41. A process as defined in claim 18 wherein the anion exchange
resin is contacted with a composition comprising a mixture of KI,
I.sub.2 and a minor amount of water, the mole ratio of KI to
I.sub.2 initially being about 1.
42. A process as defined in claim 18 wherein said anion exchange
resin is in the hydroxyl form OH.sup.-, wherein the anion exchange
resin is contacted with a composition consisting of a mixture of
KI, I.sub.2 and a minor amount of water, the mole ratio of KI to
I.sub.2 initially being about 1, wherein said elevated temperature
is a temperature of 102.degree. C. or higher and wherein said
elevated pressure is a pressure of 2 psig or greater.
43. A process as defined in claim 42 wherein said elevated
temperature is a temperature of 115.degree. C. or higher and
wherein said elevated pressure is a pressure of from 5 to 35
psig.
44. A process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form with a sufficient amount of an
iodine-substance absorbable by the anion exchange resin such that
the anion exchange resin absorbs said iodine-substance so as to
convert the anion exchange resin to the demand disinfectant resin,
said iodine-substance being selected from the group comprising
I.sub.2 and polyiodide ions having a valence of -1, characterized
in that said conversion step comprises an initial conversion stage
followed by a second conversion stage, in that said initial
conversion stage comprises contacting the anion exchange resin with
the iodine-substance at a temperature of 100.degree. C. or lower so
as to obtain an intermediate composition, said intermediate
composition comprising residual absorbable iodine-substance and an
intermediate iodinated resin, and in that said second conversion
stage comprises subjecting the intermediate composition to elevated
temperature and elevated pressure, said elevated temperature being
higher than 100.degree. C., said elevated pressure being greater
than atmospheric pressure.
45. A process as defined in claim 44 wherein said elevated pressure
is a pressure of 2 psig or greater.
46. A process as defined in claim 44 wherein said elevated pressure
is a pressure of 5 psig or greater.
47. A process as defined in claim 46 wherein said elevated pressure
is a pressure of up to 100 psig.
48. A process as defined in claim 44 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
49. A process as defined in claim 44 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
50. A process as defined in claim 44 wherein said initial
conversion stage comprises contacting the anion exchange resin with
the iodine-substance at a pressure of from 0 to less than 2
psig.
51. A process as defined in claim 50 wherein said elevated pressure
is a pressure of 2 psig or greater.
52. A process as defined in claim 50 wherein said elevated pressure
is a pressure of 5 psig or greater.
53. A process as defined in claim 52 wherein said elevated pressure
is a pressure of up to 100 psig.
54. A process as defined in claim 50 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
55. A process as defined in claim 50 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
56. A process as defined in claim 44 wherein said initial
conversion stage comprises contacting the anion exchange resin with
the iodine-substance at a temperature of from 20 to 40.degree. C.
and at essentially ambient pressure.
57. A process as defined in claim 56 wherein said elevated pressure
is a pressure of 2 psig or greater.
58. A process as defined in claim 56 wherein said elevated pressure
is a pressure of 5 psig or greater.
59. A process as defined in claim 58 wherein said elevated pressure
is a pressure of up to 100 psig.
60. A process as defined in claim 56 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
61. A process as defined in claim 56 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
62. A process as defined in claim 56 wherein said elevated
temperature is a temperature of 102.degree. C. or higher.
63. A process as defined in claim 56 wherein said elevated
temperature is a temperature of 115.degree. C. or higher.
64. A process as defined in claim 56 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
65. A process as defined in claim 56 wherein said elevated
temperature is a temperature of 102.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
66. A process as defined in claim 65 wherein said elevated
temperature is a temperature of up to 210.degree. C.
67. A process as defined in claim 56 wherein said elevated
temperature is a temperature of 110.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
68. A process as defined in claim 67 wherein said elevated
temperature is a temperature of up to 150.degree. C.
69. A process as defined in claim 67 wherein said elevated
temperature is of from 115.degree. C. to 135.degree. C.
70. A process as defined in claim 56 wherein said elevated
temperature is a temperature of 115.degree. C. or higher and said
elevated pressure is a pressure of from 5 to 35 psig.
71. A process as defined in claim 70 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
72. A process as defined in claim 44 wherein said first stage is
effected for a time period of 1 minute or more.
73. A process as defined in claim 56 wherein said first stage is
effected for a time period of 1 minute or more.
74. A process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form other than the iodide form I.sup.-, with a
sufficient amount of an iodine-substance absorbable by the anion
exchange resin such that the anion exchange resin absorbs said
iodine-substance so as to convert the anion exchange resin to the
demand disinfectant resin, said iodine-substance being selected
from the group comprising polyiodide ions having a valence of -1,
characterized in that said conversion step comprises an initial
conversion stage followed by a second conversion stage, in that
said initial conversion stage comprises contacting the anion
exchange resin with the iodine-substance the anion exchange resin
with the iodine-substance at a temperature of 100.degree. C. or
lower so as to obtain an intermediate composition, said
intermediate composition comprising residual absorbable
iodine-substance and an intermediate iodinated resin, and in that
said second conversion stage comprises subjecting the intermediate
composition to elevated temperature and elevated pressure, said
elevated temperature being 100.degree. C. or higher, said elevated
pressure being greater than atmospheric pressure.
75. A process as defined in claim 74 wherein said iodine-substance
comprises triiodide ions of formula I.sub.3.sup.-.
76. A process as defined in claim 74 wherein the anion exchange
resin is in the chloride form Cl.sup.-.
77. A process as defined in claim 74 wherein the anion exchange
resin is in the hydroxyl form OH.sup.-.
78. A process as defined in claim 74 wherein said elevated pressure
is a pressure of 2 psig or greater.
79. A process as defined in claim 74 wherein said elevated pressure
is a pressure of 5 psig or greater.
80. A process as defined in claim 79 wherein said elevated pressure
is a pressure of up to 100 psig.
81. A process as defined in claim 74 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
82. A process as defined in claim 74 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
83. A process as defined in claim 75 wherein said initial
conversion stage comprises contacting the anion exchange resin with
the iodine-substance at a pressure of from 0 to less than 2
psig.
84. A process as defined in claim 83 wherein said elevated pressure
is a pressure of 2 psig or greater.
85. A process as defined in claim 83 wherein said elevated pressure
is a pressure of 5 psig or greater.
86. A process as defined in claim 85 wherein said elevated pressure
is a pressure of up to 100 psig.
87. A process as defined in claim 83 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
88. A process as defined in claim 83 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
89. A process as defined in claim 75 wherein said initial
conversion stage comprises contacting the anion exchange resin with
the iodine-substance at a temperature of from 20 to 40.degree. C.
and at essentially ambient pressure (i.e. a pressure of less than 1
psig to 0 (zero) psig; 0 psig reflecting barometric or atmospheric
pressure).
90. A process as defined in claim 89 wherein said elevated pressure
is a pressure of 2 psig or greater.
91. A process as defined in claim 89 wherein said elevated pressure
is a pressure of 5 psig or greater.
92. A process as defined in claim 91 wherein said elevated pressure
is a pressure of up to 100 psig.
93. A process as defined in claim 89 wherein said elevated pressure
is a pressure of from 5 to 35 psig.
94. A process as defined in claim 89 wherein said elevated pressure
is a pressure of from 5 to 20 psig.
95. A process as defined in claim 89 wherein said elevated
temperature is a temperature of 102.degree. C. or higher.
96. A process as defined in claim 89 wherein said elevated
temperature is a temperature of 115.degree. C. or higher.
97. A process as defined in claim 89 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
98. A process as defined in claim 89 wherein said elevated
temperature is a temperature of 102.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
99. A process as defined in claim 98 wherein said elevated
temperature is a temperature of up to 210.degree. C.
100. A process as defined in claim 89 wherein said elevated
temperature is a temperature of 110.degree. C. or higher and said
elevated pressure is a pressure of 5 psig or greater.
101. A process as defined in claim 100 wherein said elevated
temperature is a temperature of up to 150.degree. C.
102. A process as defined in claim 100 wherein said elevated
temperature is of from 115.degree. C. to 135.degree. C.
103. A process as defined in claim 89 wherein said elevated
temperature is a temperature of 115.degree. C. or higher and said
elevated pressure is a pressure of from 5 to 35 psig.
104. A process as defined in claim 103 wherein said elevated
temperature is a temperature of from 115.degree. C. to 135.degree.
C.
105. A process as defined in claim 74 wherein said first stage is
effected for a time period of 1 minute or more.
106. A process as defined in claim 89 wherein said first stage is
effected for a time period of 1 minute or more.
107. A process as defined in claim 104 wherein the anion exchange
resin is in the chloride form Cl.sup.-.
108. A process as defined in claim 104 wherein the anion exchange
resin is in the hydroxyl form OH.sup.-.
109. A process as defined in claim 75 wherein the anion exchange
resin is a quaternary ammonium anion exchange resin.
110. A process as defined in claim 75 wherein the anion exchange
resin is contacted with a composition comprising a mixture of KI,
I.sub.2 and a minor amount of water, the mole ratio of KI to
I.sub.2 initially being about 1.
111. A process as defined in claim 75 wherein said anion exchange
resin is in the hydroxyl form OH.sup.-, wherein the anion exchange
resin is contacted with a composition consisting of a mixture of
KI, I.sub.2 and a minor amount of water, the mole ratio of KI to
I.sub.2 initially being about I and wherein said elevated
temperature is a temperature of 102.degree. C. or higher, and
wherein said elevated pressure is a pressure of 2 psig or
greater.
112. A process as defined in claim 111 wherein said elevated
pressure is a pressure of from 2 to 35 psig.
113. A process as defined in claim 111 wherein said first stage is
effected for a time period of from 1 minute to 24 hours.
114. A demand disinfectant resin, said disinfectant resin being an
iodinated strong base anion exchange resin which is the same as an
iodinated strong base anion exchange resin prepared in accordance
with a process as defined in claim 1.
115. A demand disinfectant resin, said disinfectant resin being an
iodinated strong base anion exchange resin whenever prepared in
accordance with a process as defined in claim 1.
116. A demand disinfectant resin, said disinfectant resin being an
iodinated strong base anion exchange resin which is the same as an
iodinated strong base anion exchange resin prepared in accordance
with a process as defined in claim 112.
117. A demand disinfectant resin, said disinfectant resin being an
iodinated strong base anion exchange resin whenever prepared in
accordance with a process as defined in claim 112.
118. A method for disinfecting air containing airborne
microorganisms, said method comprising passing said air over a
demand disinfectant resin such that airborne microorganisms contact
said resin and are devitalized thereby, said demand disinfectant
resin comprising an iodinated strong base anion exchange resin.
119. A method for disinfecting air as defined in claim 118 wherein
said iodinated strong base anion exchange resin comprises a strong
base anion exchange resin component which represents from 25 to 90
percent by weight of the total weight of the iodinated resin.
120. A method for disinfecting air as defined in claim 118 wherein
said iodinated strong base anion exchange resin comprises a strong
base anion exchange resin component which represents from 45 to 65
percent by weight of the total weight of the iodinated resin.
121. A method for disinfecting air as defined in claim 118 wherein
said iodinated strong base anion exchange resin is an iodinated
strong base anion exchange resin prepared in accordance with a
process as defined in claim 1.
122. A method for disinfecting air as defined in claim 118 wherein
said iodinated strong base anion exchange resin is an iodinated
strong base anion exchange resin prepared in accordance with a
process as defined in claim 112.
123. A system for disinfecting air containing airborne
microorganisms, said system comprising means for providing an air
path for the movement of air therethrough, and a demand
disinfectant resin disposed in said air path such that airborne
microorganisms in air passing through said air path are able to be
brought into contact with said resin and be devitalized thereby,
said demand disinfectant resin comprising an iodinated strong base
anion exchange resin.
124. A system for disinfecting air as defined in claim 123 wherein
said iodinated strong base anion exchange resin comprises a strong
base anion exchange resin component which represents from 25 to 90
percent by weight of the total weight of the iodinated resin.
125. A system for disinfecting air as defined in claim 123 wherein
said iodinated strong base anion exchange resin comprises a strong
base anion exchange resin component which represents from 45 to 65
percent by weight of the total weight of the iodinated resin.
126. A system for disinfecting air as defined in claim 123 wherein
said iodinated strong base anion exchange resin is an iodinated
strong base anion exchange resin prepared in accordance with a
process as defined in claim 1.
127. A system for disinfecting air as defined in claim 123 wherein
said iodinated strong base anion exchange resin is an iodinated
strong base anion exchange resin prepared in accordance with a
process as defined in claim 112.
128. A system for disinfecting air as defined in claim 123, said
system including means for urging the air through said air
path.
129. A system for disinfecting air as defined in claim 123, said
system including means disposed in said air path for scavenging
iodine liberated from the disinfectant resin.
130. A method for disinfecting a liquid containing microorganisms,
said method comprising passing said liquid over a demand
disinfectant resin such that microorganisms therein contact said
resin and are devitalized thereby, said disinfectant resin being an
iodinated strong base anion exchange resin which is the same as an
iodinated strong base anion exchange resin prepared in accordance
with a process as defined in claim 1.
131. A method for disinfecting a liquid containing microorganisms,
said method comprising passing said liquid over a demand
disinfectant resin such that microorganisms therein contact said
resin and are devitalized thereby, said disinfectant resin being an
iodinated strong base anion exchange resin whenever prepared in
accordance with a process as defined in claim 1.
132. A method for disinfecting a liquid containing microorganisms,
said method comprising passing said liquid over a demand
disinfectant resin such that microorganisms therein contact said
resin and are devitalized thereby, said disinfectant resin being an
iodinated strong base anion exchange resin which is the same as an
iodinated strong base anion exchange resin prepared in accordance
with a process as defined in claim 112.
133. A method for disinfecting a liquid containing microorganisms,
said method comprising passing said liquid over a demand
disinfectant resin such that microorganisms therein contact said
resin and are devitalized thereby, said disinfectant resin being an
iodinated strong base anion exchange resin whenever prepared in
accordance with a process as defined in claim 112.
134. A combination comprising a demand disinfectant component and a
carrier component, said demand disinfectant component comprising
particles of an iodinated strong base anion exchange resin, said
particles of said demand disinfectant component being held to said
carrier component.
135. A combination as defined in claim 134 wherein said particles
of said demand disinfectant component are fixed to said carrier
component, wherein said carrier component comprises a flexible
polymeric matrix and wherein particles of said demand disinfectant
are dispersed in said polymeric matrix.
136. A combination as defined in claim 135 wherein said flexible
polymeric matrix is a porous cellular polymeric matrix.
137. A combination as defined in claim 134 wherein said iodinated
strong base anion exchange resin comprises a strong base anion
exchange resin component which represents from 25 to 90 percent by
weight of the total weight of the iodinated resin.
138. A combination as defined in claim 134 wherein said iodinated
strong base anion exchange resin comprises a strong base anion
exchange resin component which represents from 45 to 65 percent by
weight of the total weight of the iodinated resin.
139. A combination as defined in claim 134 wherein said iodinated
strong base anion exchange resin is an iodinated strong base anion
exchange resin prepared in accordance with a process as defined in
claim 1.
140. A combination as defined in claim 136 wherein said iodinated
strong base anion exchange resin is an iodinated strong base anion
exchange resin prepared in accordance with a process as defined in
claim 112.
141. A sterilisation dressing, for being applied to a lesion, said
dressing comprising a demand disinfectant component and a carrier
component, said demand disinfectant component comprising particles
of an iodinated strong base anion exchange resin, said carrier
component being configured so as to hold onto particles of said
demand disinfectant component such that microorganisms are able to
be brought into contact with said particles and be devitalised
thereby, said carrier component being of a pharmaceutically
acceptable material.
142. A dressing as defined in claim 141 wherein said carrier
component is flexible and has an outer surface and wherein
particles of said demand disinfectant are fixed to at least a
portion of said outer surface.
143. A dressing as defined in claim 141 wherein said carrier
component is flexible and comprises a porous cellular polymeric
matrix, wherein particles of said demand disinfectant are dispersed
in said polymeric matrix.
144. A dressing as defined in claim 141 wherein said iodinated
strong base anion exchange resin comprises a strong base anion
exchange resin component which represents from 25 to 90 percent by
weight of the total weight of the iodinated resin.
145. A dressing as defined in claim 141 wherein said iodinated
strong base anion exchange resin comprises a strong base anion
exchange resin component which represents from 45 to 65 percent by
weight of the total weight of the iodinated resin.
146. A dressing as defined in claim 141 wherein said iodinated
strong base anion exchange resin is an iodinated strong base anion
exchange resin prepared in accordance with a process as defined in
claim 1.
147. A dressing as defined in claim 141 wherein said iodinated
strong base anion exchange resin is an iodinated strong base anion
exchange resin prepared in accordance with a process as defined in
claim 112.
148. A dressing as defined in claim 143 wherein said iodinated
strong base anion exchange resin is an iodinated strong base anion
exchange resin prepared in accordance with a process as defined in
claim 112.
149. A method for disinfecting air containing airborne
microorganisms, said method comprising passing said air over a
disinfectant resin such that airborne microorganisms contact said
resin and are devitalized thereby, said disinfectant resin
comprising a disinfectant iodinated resin.
150. A system for disinfecting air containing airborne
microorganisms, said system comprising means for providing an air
path for the movement of air therethrough, and a disinfectant resin
disposed in said air path such that airborne microorganisms in air
passing through said air path are able to be brought into contact
with said resin and be devitalized thereby, said disinfectant resin
comprising a disinfectant iodinated resin.
151. A combination comprising a disinfectant component and a
carrier component, said disinfectant component comprising particles
of an iodinated resin, said particles of said disinfectant
component being held to said carrier component.
152. A sterilisation dressing, for being applied to a lesion, said
dressing comprising a disinfectant component and a carrier
component, said disinfectant component comprising particles of an
iodinated resin, said carrier component being configured so as to
hold onto particles of said disinfectant component such that
microorganisms are able to be brought into contact with said
particles and be devitalised thereby, said carrier component being
of a pharmaceutically acceptable material.
Description
[0001] The present application is a continuation-in-part of U.S.
patent application no. 07/957,307 filed Sep. 16, 1992 and of U.S.
patent application no. 08/047,535 filed on Apr. 19, 1993.
[0002] The present invention relates to a disinfectant substance
comprising an iodine (impregnated) resin and to a process for the
preparation thereof. The iodine/resin disinfectant may be used to
sterilize a fluid such as, for example, water, air, as well as
fluid exudate secreted at body lesions or traumas such as at cuts,
burns , etc.; thus, the disinfectant may be used to devitalize
microorganisms (e.g. bacteria, viruses, etc . . . ) which may be
present in the fluid (e.g. water, air, pus and the like). The
treatment of fluid, such as water or air, with an iodine/resin
disinfectant of the present invention may leave behind
non-detectable (or acceptable) residual diatomic iodine in the
fluid (e.g. water or air). The present invention in particular
relates to a demand type broad spectrum resin-polyiodide (e.g.
water, air, wound) disinfectant.
[0003] Diatomic halogen (such as I.sub.2, Cl.sub.2, Br.sub.2, etc .
. . ) has traditionally been used to disinfect water. Diatomic
chlorine, for example, is a widely exploited disinfectant for
controlling or eliminating micro-organisms which may be present in
water. A disadvantage of a sterilization regime which exploits
diatomic halogen is that the regime may leave behind unacceptable
(residual) levels of halogen in the water once sterilization is
complete.
[0004] An iodine/resin product has, however, been proposed for use
as a demand disinfectant, namely a disinfectant wherein iodine is
released almost entirely on a demand-action basis. U.S. Pat. Nos.
3,817,860, 3,923,665, 4,238,477 and 4,420,590 teach such a demand
disinfectant wherein iodine is the active disinfectant agent; the
entire contents of each of these patents is incorporated herein by
reference. In accordance with the teachings of these patents the
resin product may be used without fear of introducing unacceptable
concentrations of diatomic iodine into the water to be
sterilized.
[0005] U.S. Pat. Nos. 3,817,860 and 3,923,665 teach an iodine/resin
demand disinfectant which is the reaction product obtained by
contacting a strong base anion exchange resin with a suitable
source of triiodide ions. The reaction product is taught as being
very stable in the sense that the amount of iodine (e.g. .sub.2)
released into water from the reaction product is sufficiently low
that the water disinfected thereby is immediately ready for use,
ie. as drinking water.
[0006] In accordance with the teachings of U.S. Pat. Nos. 3,817,860
and 3,923,665 the procedure for preparing the iodine/resin
comprises forming a triiodide ion (solution or sludge) by
dissolving diatomic iodine in a water solution of a suitable alkali
metal halide (e.g. KI, NaI, . . . ). The triiodide solution is in
particular taught as being made with a minimal (i.e. minor) water
content just sufficient to avoid causing the I.sub.2 to crystallize
out; see example 1 of U.S. Pat. No. 3,923,665. The resulting
(solution) containing the triiodide ion is then contacted with the
starting resin (under ambient conditions with respect to
temperature (i.e. 25 to 30.degree. C.) and pressure), the triiodide
ions exchanging with the anion of the resin (e.g. exchange with
chlorine, sulfate, etc., . . . ). The starting resin is taught as
being a porous granular strong base anion exchange resin having
strongly basic groups in a salt form wherein the anion thereof is
exchangeable with triiodide ions. In accordance with the teachings
of the above prior art references contacting is continued until the
desired amount of triiodide has reacted with the strongly basic
groups such that bacterially contaminated water is disinfected when
passed through a bed of the obtained resin. After a suitable
contact time the iodine/resin is (water) washed to remove
water-elutable iodine from the resin product.
[0007] However, as indicated in U.S. Pat. No. 4,238,477, it is
difficult to use the procedures outlined in the two previously
mentioned U.S. patents so as to obtain a homogeneous iodine/resin
product containing only triiodide anions and wherein all of the
active sites of the resin have been converted to triiodide
ions.
[0008] Accordingly, U.S. Pat. No. 4,238,477 teaches an alternate
process whereby the iodine/resin may be produced. In accordance
with this alternate impregnation/contact process, a suitable resin
in the iodide form (I.sup.-) is contacted with water comprising
diatomic iodine (I.sub.2) in solution, the water being recycled
between a source of a predetermined amount of diatomic iodine and
the resin. The process as taught by this latter patent, however, is
a relatively complicated system of pumps, vessels, heaters, etc.;
by exploiting a fluidized bed, it in particular may lead to a
significant degree of resin bead attrition, i.e. particle
breakup.
[0009] The processes as taught in U.S. Pat. Nos. 3,817,860 and
3,923,665 are carried out at ambient temperature and ambient
pressure conditions. The U.S. Pat. No. 4,238,477 teaches that the
contact may occur at a higher temperature such as 60 to 95.degree.
C. but that the temperature must be a non-boiling temperature (with
respect to water); see column 3 lines 55 to 66.
[0010] The above referred to U.S. patents teach the use of the
demand disinfectant iodinated resins for treating water; see also
U.S. Pat. Nos. 4,298,475 and 4,995,976 which teach water
purification devices or systems which exploit iodinated resins.
None of these patents teaches the use of the iodinated resins for
the purpose of sterilizing air.
[0011] It is also known to use iodine tincture for sterilising
wounds. The sterilisation effect of iodine tincture is short lived;
this means that the tincture must be reapplied on a regular basis
to maintain the sterilisation effect. However, such solutions may
also damage or destroy the tissue around the wound if applied too
liberally and too often. Additionally, the direct application of
such solutions to a lesion or wound is usually accompanied by a
painful sensation.
[0012] Accordingly it would be advantageous to have a iodine/resin
product which has improved characteristics over known or
commercially available iodine/resin disinfectant products.
[0013] It would also be advantageous to have an alternate process
for the preparation of a iodine/resin product (which has improved
characteristics over the previously known iodine/resin).
[0014] It would be advantageous to have an alternative effective
demand disinfectant (e.g. bactericidal) resin and an effective
technique for the manufacture thereof. It would, in particular, be
advantageous to have an iodine/resin demand disinfectant having a
relatively low level of iodine bleed into a fluid (such as water or
air) being treated as well as an iodine impregnation process for
obtaining such iodinated resin.
[0015] It would also be advantageous to have a means whereby
lesions, such as for example wounds or burns, may be treated in
order to facilitate healing by devitalising microorganisms which
may already be in the area of the lesion and further to prevent
microorganisms from having access to such lesion (i.e. a dressing),
i.e. to inhibit access from any outside biovectors such as for
example airborne, waterborne, spital borne, blood borne,
particulate borne microorganisms and the like.
[0016] It would additionally be advantageous to have a means for
inhibiting or preventing microorganisms from contacting
predetermined areas of the body such as the skin (e.g. a protective
textile for making protective clothing).
[0017] In accordance with a general aspect, the present invention
provides a process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, (i.e. a demand disinfectant-resin comprising polyiodide
ions, having a valence of -1, the ions being absorbed or
impregnated into the resin as herein described) ,
[0018] the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form with a sufficient amount of an
iodine-substance absorbable by the anion exchange resin such that
the anion exchange resin absorbs said iodine-substance so as to
convert the anion exchange resin to the disinfectant-resin, said
iodine-substance being selected from the group comprising I.sub.2
(i.e. diatomic iodine) and polyiodide ions having a valence of
-1,
[0019] characterized in that for the conversion step at least a
portion of the absorption of iodine-substance is effected at
elevated temperature and at elevated pressure, said elevated
temperature being 100.degree. C. or higher (e.g. a temperature
higher than 100.degree. C. such as, for example, 102.degree. C.,
103.degree. C., 104.degree. C., 105.degree. C., 110.degree. C.,
115.degree. C., 150.degree. C., etc.), said elevated pressure being
greater than atmospheric pressure (e.g. a pressure greater than
barometric pressure such as for example 2 psig, 3 psig, 4 psig, 5
psig, 15 psig, 25 psig, 35 psig, 100 psig, etc.).
[0020] In accordance with the present invention the
disinfectant-resin may be one in which diatomic iodine is
incorporated. The disinfectant polyiodide-resin may in particular
be triiodide-resin. Thus, for example, the iodine-substance may
comprise triiodide ion of formula I.sub.3.sup.-, i.e. so as to form
a disinfectant-resin which comprises (absorbed) triiodide ions of
formula I.sub.3.sup.-.
[0021] The terms "triiodide", "triiodide ion" and the like, as used
in the context herein, refer to or characterize a substance or a
complex as containing three iodine atoms and which has a valence of
-1. The triiodide ion herein therefore is a complex ion which may
be considered as comprising molecular iodine (i.e. iodine as
I.sub.2) and an iodine ion (i.e. I.sup.-). Similarly the terms
"polyiodide". "polyiodide ions" and the like, refer to or
characterize a substance or a complex as having three or more
iodine atoms and which may be formed if more of the molecular
iodine combines with the monovalent triiodide ion. These terms are
more particularly described in the above referred to U.S.
patents.
[0022] In accordance with a further aspect, the present invention
provides a process for preparing a demand disinfectant resin, said
disinfectant resin being an iodinated strong base anion exchange
resin, (i.e. a demand disinfectant-resin comprising polyiodide
ions, having a valence of -1, the ions being absorbed or
impregnated into the resin as herein described),
[0023] the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form other than the iodide form I.sup.-, with a
sufficient amount of an iodine-substance absorbable by the anion
exchange resin such that the anion exchange resin absorbs said
iodine-substance so as to convert the anion exchange resin to the
disinfectant-resin, said iodine-substance being selected from the
group comprising polyiodide ions having a valence of -1,
[0024] characterized in that for the conversion step at least a
portion of the absorption of iodine-substance is effected at
elevated temperature and at elevated pressure, said elevated
temperature being 100.degree. C. or higher (e.g. a temperature
higher than 100.degree. C.), said elevated pressure being greater
than atmospheric pressure (e.g. a pressure greater than barometric
pressure).
[0025] The strong base anion exchange resin may be in a salt form
such as for example a chloride or hydroxyl form.
[0026] The conversion in accordance with the present invention may
essentially or at least partially be effected at said elevated
temperature and elevated pressure. The conversion, in accordance
with the present invention, may, thus for example, be effected in
one, two or more stages. For example, the elevated
pressure/temperature conditions may be divided between two
different pairs of elevated pressure/temperature conditions, e.g.
an initial pressure of 15 psig and a temperature of 121.degree. C.
and a subsequent pressure of 5 psig and a temperature of
115.degree. C.
[0027] If the conversion is to be carried out in two stages, it may
for example, comprise a first stage followed by a second stage. The
first stage may, for example, be effected at low temperature
conditions (e.g. at ambient temperature and ambient pressure
conditions) whereas the second stage may be effected at elevated
conditions such as described herein. Thus, the present invention,
in accordance with another aspect provides a process for preparing
a demand disinfectant resin, said disinfectant resin being an
iodinated strong base anion exchange resin, (i.e. a demand
disinfectant-resin comprising polyiodide ions, having a valence of
-1, the ions being absorbed or impregnated into the resin as herein
described),
[0028] the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form with a sufficient amount of an
iodine-substance absorbable by the anion exchange resin such that
the anion exchange resin absorbs said iodine-substance so as to
convert the anion exchange resin to the demand disinfectant resin,
said iodine-substance being selected from the group comprising
I.sub.2 and polyiodide ions having a valence of -1,
[0029] characterized in that said conversion step comprises an
initial conversion stage followed by a second conversion stage,
[0030] in that said initial conversion stage comprises contacting
the anion exchange resin with the iodine-substance at a temperature
of 100.degree. C. or lower so as to obtain an intermediate
composition, said intermediate composition comprising residual
absorbable iodine-substance and an intermediate iodinated resin,
(i.e. a resin comprising absorbed polyiodide ions having a valence
of -1), and
[0031] in that said second conversion stage comprises subjecting
the intermediate composition to elevated temperature and elevated
pressure, said elevated temperature being 100.degree. C. or higher
(e.g. a temperature higher than 100.degree. C.), said elevated
pressure being greater than atmospheric pressure.
[0032] In accordance with a further particular aspect, the present
invention provides a process for preparing a demand disinfectant
resin, said disinfectant resin being an iodinated strong base anion
exchange resin, (i.e. a demand disinfectant-resin comprising
polyiodide ions, having a valence of -1, the ions being absorbed or
impregnated into the resin as herein described),
[0033] the process comprising a conversion step, the conversion
step comprising contacting a porous strong base anion exchange
resin in a salt form other than the iodide form I.sup.- with a
sufficient amount of an iodine-substance absorbable by the anion
exchange resin such that the anion exchange resin absorbs said
iodine-substance so as to convert the anion exchange resin to the
disinfectant-resin, said iodine-substance being selected from the
group comprising polyiodide ions having a valence of -1,
[0034] characterized in that said conversion step comprises an
initial conversion stage followed by a second conversion stage,
[0035] in that said initial conversion stage comprises contacting
the anion exchange resin with the iodine-substance at a temperature
of 100.degree. C. or lower so as to obtain an intermediate
composition, said intermediate composition comprising residual
absorbable iodine-substance and an intermediate iodinated resin
(i.e. a resin comprising absorbed polyiodide ions having a valence
of -1), and
[0036] in that said second conversion stage comprises subjecting
the intermediate composition to elevated temperature and elevated
pressure, said elevated temperature being 100.degree. C. or higher
(e.g. a temperature higher than 100.degree. C.), said elevated
pressure being greater than atmospheric pressure.
[0037] In accordance with the present invention, for the first
stage, the low temperature may, for example, be a non-boiling
temperature of not more than 95.degree. C.; e.g. 15 to 60.degree.
C.; e.g. ambient temperature or room temperature such as a
temperature of from about 15.degree. C. to about 40.degree. C.,
e.g. 20 to 30.degree. C. The pressure associated with the low
temperature condition of the first stage may, for example, be a
pressure of from 0 (zero) to less than 2 psig; the pressure may in
particular be essentially ambient pressure (i.e. a pressure of less
than 1 psig to 0 (zero) psig; 0 psig reflecting barometric or
atmospheric pressure).
[0038] In accordance with the present invention, for the second
stage, the elevated temperature may, for example, be: a temperature
of 102.degree. C. or higher; e.g. 105.degree. C. or higher; e.g.
110.degree. C. or higher; e.g. 115.degree. C. or higher; e.g. up to
150.degree. C. to 210.degree. C.; e.g. 115.degree. C. to
135.degree. C. The elevated pressure associated with the elevated
temperature condition of the second stage may, for example, be: a
pressure of 2 psig or greater; e.g. 5 psig or greater; e.g. 15 psig
to 35 psig; e.g. up to 100 psig.
[0039] The present invention further relates to any demand
disinfectant resin, the disinfectant resin being an iodinated
strong base anion exchange resin which is the same as an iodinated
strong base anion exchange resin prepared in accordance with a
process as defined herein; an iodinated resin the same as a resin
prepared in accordance with the (particular) process described
herein is one which has the same low iodine bleed characteristic,
i.e. the iodine is (more) tenaciously associated with the resin
than for previously known iodinated resins. It in particular
relates to a demand disinfectant resin, the disinfectant resin
being an iodinated strong base anion exchange resin whenever
prepared in accordance with a process as defined herein.
[0040] The present invention also relates to the use of iodinated
resins to disinfect fluids containing microorganisms, such fluids
including air, water, pus, and the like. The iodinated resin may
for example be a known resin such as discussed herein, a resin in
accordance with the present invention, nylon based resin beads
impregnated with iodine (such as MCV resin from MCV Tech. Intn'l
Inc.), and the like.
[0041] Thus the present invention also provides a method for
disinfecting air containing airborne microorganisms, said method
comprising passing said air over a disinfectant resin such that
airborne microorganisms contact said resin and are devitalized
thereby, said disinfectant resin comprising an iodinated resin. The
disinfectant resin may, for example, be a demand disinfectant
resin. The disinfectant resin may, for example, comprise an
iodinated strong base anion exchange resin.
[0042] The present invention further provides a system for
disinfecting air containing airborne microorganisms, said system
comprising
[0043] means for providing an air path for the movement of air
therethrough, and
[0044] a disinfectant resin disposed in said air path such that
airborne microorganisms in air passing through said air path are
able to be brought into contact with said resin and be devitalized
thereby,
[0045] said disinfectant resin comprising an iodinated resin. The
disinfectant resin may, for example, be a demand disinfectant
resin. The disinfectant resin may, for example, comprise an
iodinated strong base anion exchange resin.
[0046] The present invention additionally provides a combination
comprising
[0047] a disinfectant component and
[0048] a carrier component,
[0049] said disinfectant component comprising particles of an
iodinated resin,
[0050] said particles of said disinfectant component being held
(e.g. fixed) to said carrier component. The disinfectant component
may, for example, be a demand disinfectant component. The
disinfectant resin may, for example, comprise an iodinated strong
base anion exchange resin. The combination may be used as a means
for providing a barrier or shield for the body against
microorganisms. The combination may thus, for example, be
incorporated into a textile or other wearing apparel starting
material in the form of a layer (e.g. a liner layer). The obtained
raw wearing apparel material may then be used to make a protective
garment, glove, sock, footwear (e.g. shoe), helmet, face mask and
the like; the obtained wearing apparel may be worn in hazardous
environments to protect the wearer from contact with viable
microorganisms. The combination as desired or as necessary may
flexible or stiff; depending on the nature of the carrier component
and also on the form of the resin (e.g. plate, particle, etc.).
[0051] The present invention in a more particular aspect provides a
sterilisation dressing, for being applied to a lesion, (such as a
sore, a wound (e.g. cut), an ulcer, a boil, an abrasion, a burn or
other lesion of the skin or internal organ), said dressing
comprising
[0052] a disinfectant component and
[0053] a carrier component,
[0054] said disinfectant component comprising particles of an
iodinated strong base anion exchange resin,
[0055] said carrier component being configured so as to hold onto
particles of said disinfectant component such that microorganisms
are able to be brought into contact with said particles and be
devitalised thereby,
[0056] said carrier component being of a pharmaceutically
acceptable material. The disinfectant component may, for example,
be a demand disinfectant. The disinfectant resin may, for example,
comprise an iodinated strong base anion exchange resin. The carrier
component may be stiff or it may be flexible as desired. The
(sterilization) dressing may, for example, be applied over a wound
or burn and be held in place over the time period needed for the
body to repair the damaged area; the dressing during this time will
act not only as a barrier or shield to prevent infectious
microorganisms from contacting the lesion but also to sterilize the
immediate area around the lesion including sterilising any fluid
exudate such as pus which may exude from the lesion. Surprisingly,
it has, for example, been found that even with relatively prolonged
exposure of (guinea pig) skin to the active element of the dressing
(i.e. the demand disinfectant) no irritation or inflammation was
noted. It has also surprisingly been found that the dressing may
effect infectious agents deep beneath the skin or dressing. The
healing process may thus be hastened by the application of a
(sterilization) dressing in accordance with the present
invention.
[0057] The demand disinfectant for the above mentioned method and
system for treating air as well as for the combination and the
dressing may be an iodinated resin produced in accordance with the
present invention or it may be a known demand disinfectant
iodinated resin such as for example as mentioned herein.
[0058] The demand disinfectant depending on the intended use may
take on any desired form; it may be bulk form; it may be in sheet
form; it may be in particulate or granular form (e.g. particles of
resin of from 0.2 mm to 1 cm in size), etc . . .
[0059] It is to be understood herein, that if a "range" or "group
of substances" is mentioned with respect to a particular
characteristic (e.g. temperature, pressure, time and the like) of
the present invention, the present invention relates to and
explicitly incorporates herein each and every specific member and
combination of sub-ranges or sub-groups therein whatsoever. Thus,
any specified range or group is to be understood as a shorthand way
of referring to each and every member of a range or group
individually as well as each and every possible sub-ranges or
sub-groups encompassed therein; and similarly with respect to any
sub-ranges or sub-groups therein. Thus, for example,
[0060] with respect to a pressure greater than atmospheric, this is
to be understood as specifically incorporating herein each and
every individual pressure state, as well as sub-range, above
atmospheric, such as for example 2 psig, 5 psig, 20 psig, 35.5
psig, 5 to 8 psig, 5 to 35, psig 10 to 25 psig, 20 to 40 psig, 35
to 50 psig, 2 to 100 psig, etc . . . ;
[0061] with respect to a temperature greater than 100.degree. C.,
this is to be understood as specifically incorporating herein each
and every individual temperature state, as well as sub-range, above
100.degree. C., such as for example 101.degree. C., 110.degree. C.
and up, 115.degree. C. and up, 115.degree. C. and up, 110 to
135.degree. C., 115.degree. C. to 135.degree. C., 102.degree. C. to
150.degree. C., up to 210.degree. C., etc.;
[0062] with respect to a temperature lower than 100.degree. C.,
this is to be understood as specifically incorporating herein each
and every individual temperature state, as well as sub-range, below
100.degree. C., such as for example 15.degree. C. and up,
15.degree. C. to 40.degree. C., 65.degree. C. to 95.degree. C.,
95.degree. C. and lower, etc.;
[0063] with respect to residence or reaction time, a time of 1
minute or more is to be understood as specifically incorporating
herein each and every individual time, as well as sub-range, above
1 minute, such as for example 1 minute, 3 to 15 minutes, 1 minute
to 20 hours, 1 to 3 hours, 16 hours, 3 hours to 20 hours etc.;
[0064] and similarly with respect to other parameters such as low
pressures, concentrations, elements, etc . . .
[0065] It is also to be understood herein that "g" or "gm" is a
reference to the gram weight unit; that "C" is a reference to the
celsius temperature unit; and "psig" is a reference to "pounds per
square inch guage".
[0066] In drawings which illustrate example embodiments of the
present invention:
[0067] FIG. 1 is a graph of showing the ppm of Iodine in the
effluent versus the total volume of water contacted with a
disinfectant-resin bed of the prior art and an example disinfectant
resin of the present invention;
[0068] FIG. 2 is a graph of the number of microorganisms in
effluent versus the total volume of contaminated water contacted
with a disinfectant resin of the prior art and an example
disinfectant resin of the present invention;
[0069] FIG. 3 is a perspective view of a cartridge which may be
used to house an iodinated resin as described herein for use for
example in a gas mask;
[0070] FIG. 4 is a cross sectional view 4-4 of the cartridge of
FIG. 1;
[0071] FIG. 5 is a schematic illustration of a system for testing a
cartridge containing an iodinated resin;
[0072] FIG. 6 is a schematic illustration of another type of system
for testing a cartridge containing an iodinated resin;
[0073] FIG. 7 is a partially cut away perspective view of a
sterilisation dressing of tea-bag type construction wherein the
iodinated resin particles are free flowing but are held together by
being enveloped by a fluid (e.g. air-liquid) permeable envelope of
paper, gauze, plastics material, etc.;
[0074] FIG. 8 is a perspective view of a band-aid type sterlization
dressing, wherein the iodinated resin particles are fixed to a
central portion of an outer surface of a flexible band-aid
carrier;
[0075] FIG. 9 is a perspective partially cut away view of a
sterilisation foam or sponge type dressing comprising a flexible
foam matrix having iodinated resin particles dispersed therein, the
foam matrix having a relatively small pore size structure;
[0076] FIG. 10 is a perspective partially cut away view of a
sterilisation foam or sponge type dressing comprising a flexible
foam matrix having iodinated resin particles dispersed therein, the
foam matrix having a relatively large pore size structure; and
[0077] FIG. 11 is a cross sectional view of a sandwich type of
textile material for use in the preparation of protective clothing,
the textile including a layer of a flexible foam matrix such as is
shown in FIG. 10.
[0078] In accordance with the present invention, the elevated
temperature may as mentioned above, for example, be in the range of
from 105.degree. C. to 150.degree. C.; the elevated pressure may be
5 psig and up.
[0079] In accordance with the process of the present invention the
anion exchange resin may, for example, as described below, be a
quaternary ammonium anion exchange resin; the anion exchange resin
may be in the chloride form Cl.sup.-, in the hydroxyl form
OH.sup.-; etc . . .
[0080] In accordance with the present invention the obtained
iodide-resin may be treated prior to use to remove any
water-elutable iodine from the iodide-resin. The treatment (e.g.
washing) may be continued until no detectable iodine is found in
wash water (the wash water initially being ion free water). Any
suitable (known) iodine-test procedure may be used for iodine
detection purposes (see for example the above mentioned U.S.
patents.
[0081] In accordance with the present invention, the absorbable
iodine substance may, for example, be provided by a composition
consisting of mixture of KI, I.sub.2 and a minor amount of water,
the mole ratio of KI to I.sub.2 initially being about 1; the
expression "minor amount of water" as used herein shall be
understood as characterizing the amount of water as being
sufficient to avoid I.sub.2 crystallization.
[0082] The present invention in a further aspect provides an
enhanced iodine/resin demand disinfectant product in which more
iodine may be distributed throughout and be more tenaciously
associated with the resin (e.g. beads) than with the previously
known or commercially available techniques, the disinfectant being
produced by a process as described herein. The invention more
particularly provides an enhanced triiodide-resin disinfectant.
[0083] The present invention can be practised with any (known)
strong base anion exchange resin (for example, with those such as
are described in more detail in the above-mentioned United States
patents such as U.S. Pat. No. 3,923,665). A quaternary ammonium
anion exchange resin is, however, preferred. As used herein, it is
to be understood that the expression "strong base anion exchange
resin" designates a class of resins which either contain strongly
basic "cationic" groups, such as quaternary ammonium groups or
which have strongly basic properties which are substantially
equivalent to quaternary ammonium exchange resins. U.S. Pat. Nos.
3,923,665 and 3,817,860 identify a number of commercially available
quaternary ammonium resins, as well as other strong base resins
including tertiary sulphonium resins, quaternary phosphonium
resins, alkyl pyridinium resins and the like.
[0084] Commercially available quaternary ammonium anion exchange
resins which can be used in accordance with the present invention
include in particular, Amberlite IRA-401 S, Amberlite IR-400
(Cl.sup.-) , Amberlite IR-400 (OH.sup.-), Amberlite IR-402
(CI.sup.-), etc., (from Rohm & Hass) which may be obtained in
granular form. These resins may for example, contain quaternary
ammonium exchange groups which are bonded to styrene-divinyl
benzene polymer chains.
[0085] The resins which may be used herein may be in a hydroxyl
form, a chloride form or in another salt (e.g. sulphate) form
provided that the anion is exchangeable with the iodine member
(e.g. with triiodide ion).
[0086] The starting resin may, for example, be granular (i.e.
comprise a plurality of particles) such that the final product will
likewise have a granular or particulate character; the granular
form is advantageous due to the high surface area provided for
contact with microorganisms. The starting resin may, for example,
comprise granules having a size in the range of from 0.2 mm to 0.8
cm (e.g. of from 0.35 mm to 56 mm).
[0087] Commercially available resins such as those mentioned above
are available in the salt form (e.g. as the chloride) and in the
form of porous granular beads of various mesh sizes; the resin may
of course be used in a bulk or massive form such as a plate, sheet,
etc . . .
[0088] In accordance with the present invention, for example, a
resin may be converted from a non-iodide form (e.g. a chloride
form, a sulphate form) to the I.sub.3.sup.-form. Suitable halide
salts include alkali metal halides (such as KI, NaI, . . . );
potassium iodide is preferred. Alternatively, an iodide form of the
resin may be used and the resin contacted with a source of diatomic
iodine.
[0089] In accordance with the present invention any material or
substance capable of donating an iodine-member absorbable by the
anion exchange resin so as to convert the anion exchange resin to
the desired polyiodide-resin may be used, as long as the denotable
iodine-member thereof is a polyiodide ion having a valence of -1
and/or diatomic iodine. Examples of such materials in relation to
iodine are shown in the above mentioned U.S. patents; e.g.
compositions comprising iodine (I.sub.2) and alkali metal halide
(KI, NaI, etc . . . , KI being preferred) in association with
water. Alternatively, if the resin is in an iodide salt form
(I.sup.-1), the material may comprise the corresponding iodine in
gaseous form.
[0090] Thus, for example, if a triiodide-resin is desired the resin
may be contacted with an alkali metal iodide/I.sub.2 mix wherein
the iodide and the diatomic iodine are present in more or less
stoichiometric amounts (i.e. a mole ratio of 1); see the previously
mentioned U.S. patents. By applying stoichiometric amounts of the
iodine ion and iodine molecule (i.e. one mole of I.sub.2 per mole
of I.sup.-1), the iodide sludge will comprise substantially only
the triiodide ions. If stoichiometric excess quantities of I.sub.2
are used some of the higher polyiodide ions may be formed.
Preferably, no more than the stoichiometric proportions of I.sup.-
and I.sub.2 are used in the initial aqueous starting sludge so that
substantially only triiodided attaches to the resin.
[0091] For example iodine may be combined with sodium, potassium or
ammonium iodide and some water. The composition will contain
monovalent iodine ion which will combine with diatomic iodine
(I.sub.2) to form polyiodide ion. The molar ratio of iodine ion to
diatomic iodine will dictate the nature of the polyiodide ion
present , i.e. triiodide ion, mixtures of triiodide ion and other
higher polyiodides ions, pentaiodide ion, etc . . . Using about 1
mole of iodine ion per mole of diatomic iodine the formation of
triiodide ion will be favoured. If stiochiometric excess of
diatomic iodine is used this will favour the formation of higher
polyiodides.
[0092] The determination of the (total) amount of iodine to be
contacted with the resin, residence times etc . . . , will depend
upon such factors as the nature of the polyiodide it is desired to
introduce into the structure of a resin; the nature of the starting
resin (i.e. porosity, grain size, equivalent exchange capacity of
the resin, etc.), etc . . . Thus, for example, to determine the
amount of iodine required to prepare a polyiodide resin, the
equivalent exchange capacity of the resin needs to be known. If
necessary, this can be readily determined for example by the
procedure described in U.S. Pat. No. 3,817,860 (column 9, lines 15
to 28). The components of the process may be chosen such that the
obtained iodinated strong base anion exchange resin may comprise a
strong base anion exchange resin component which represents from 25
to 90 (preferably 45 to 65) percent by weight of the total weight
of the obtained iodinated resin.
[0093] The conversion at elevated conditions, in accordance with
the present invention, may be effected in a reactor which is
pressure sealable during conversion but which may be opened for
recovery of the resin product after a predetermined reaction time.
The process may thus be a batch process wherein conversion at
elevated temperature and pressure is effected once the reactor is
sealed. In accordance with the present invention the reactor may be
sized and the amount of reactants determined so as to provide a
void space in the reactor during reaction. In the case, for
example, wherein the material having the denotable iodine-member is
a sludge of alkali metal/I.sub.2 and water, the weight ratio of
sludge to resin may be 1:1 or higher, eg. 1:1 to 5:1; a weight
ratio of 1:1 (if Amberlite 401-S is used as the resin) is preferred
so as to minimize the amount of unabsorbed iodine which must be
washed from the iodine/resin product.
[0094] The high temperature/pressure contact conditions may as
mentioned above be chosen with a view to maximizing the iodine
content of the obtained iodine (e.g. iodine) demand resin.
[0095] In accordance with the present invention conversion of the
resin to a polyhalide (e.g. I.sub.3.sup.-) form may be effected at
elevated temperature greater than 100.degree. C., for example in
the range of 105.degree. C. to 150.degree. C. (e.g. 110-115.degree.
C. to 150.degree. C.); the upper limit of the temperature used
will, for example, depend on the characteristics of the resin being
used, i.e. the temperature should not be so high as to degrade the
resin.
[0096] As mentioned in order to effect the conversion at elevated
pressure, the conversion may take place in a closed vessel or
reactor. The pressure in such case may be a function of the
temperature such that the pressure may vary with the temperature
approximately in accordance with the well known gas equation
PV=nRT, wherein V=the constant (free) volume of the reactor,
n=moles of material in the reactor, R is the universal gas
constant, T is the temperature and P is the pressure. In a closed
vessel, the temperature of the system may therefore be used as a
means of achieving or controlling the (desired) pressure in the
vessel depending upon the makeup of the Iodine mix in the reactor.
Thus in accordance with the present invention, a reaction mix
disposed in a pressure sealed reactor may be, for example,
subjected to a temperature of 105.degree. C. and a pressure of 200
mmHg, the pressure being induced by steam.
[0097] Alternatively, a relatively inert gas may be used to induce
and/or augment the pressure in the reactor. Thus, a pressurized
relatively inert gas may be injected into a sealed reactor. The
chosen gas must not unduly interfer with the production of a
suitable iodinated resin. The high temperature/pressure treatment
may be conducted in a closed reactor in the presence of (trapped
air), a non-interfering gas such as iodine itself or of some other
relatively inert (noble) gas; the pressure as mentioned above may
be augmented by the pressuring gas. Air, carbon dioxide, nitrogen
or the like may also be used as a pressuring gas, if desired,
keeping in mind, however, that the use thereof must not unduly
interfer with the production of a suitable iodinated resin. If
pressure is to be induced by steam then as mentioned below steps
should be taken to isolate the reaction mix from (excess)
water.
[0098] In accordance with the present invention, the elevated
pressure is any pressure above ambient. The pressure may, for
example, be 1 psig or higher, e.g in the range from 5 to 50 psig;
the upper limit of the pressure used will also, for example, depend
on the characteristics of the resin being used, i.e. the pressure
should not be so high as to degrade the resin.
[0099] The residence or contact time at the elevated conditions is
variable depending upon the starting materials, contact conditions
and amount of (tenaciously held) iodine it is desired to be
absorbed by the anion exchange resin. The contact time may thus
take on any value; usually, however, it is to be expected that it
will be desired that the contact time (under the conditions used)
be sufficient to maximize the amount of (tenaciously held) iodine
absorbed from the material containing the absorbable iodine moiety.
The residence time may for example be as little as 5 to 15 minutes
(in the case where a preimpregnation step is used as shall be
described below) or several hours or more ( up to 8 or 9 hours or
more). The residence time exploited for elevated the conditions, in
any event, will as mentioned above depend on the starting material,
temperature and pressure conditions, etc . . . ; it may vary from
several minutes to 8 or 9 hours or more; the upper time limit will
in any event also, for example, depend on the characteristics of
the resin being used, i.e. the residence time should not be so high
as to degrade the resin.
[0100] Preferably, the contact at high temperature/pressure is
preceded by an initial impregnation or absorption step (first
stage). Such first stage may be carried out for only a few minutes
(e.g. for from 1 to 10 minutes or more) or for up to 24 hours or
more (e.g. for from one hour or more i.e. for from three to
twenty-four hours). The time period of the initial stage may be
relatively short. The time period, for example, may be a few
minutes or so and may correpond to the time necessary to just mix
the reactants together; in this case the conversion may be
considered to be essentially carried out in a single stage at
elevated conditions. The residence time of the first stage will
also be predetermined with a view to the end product resin desired.
For example, a water containing sludge of triiodide ions can be
contacted with a salt form of the starting resin at ambient (i.e.
room) temperature and pressure conditions to obtain an intermediate
iodide-resin reaction product including residual iodine-substance.
This step is preferably carried out in a batch reactor; the
obtained intermediate composition comprising an intermediate
iodide-resin may then be subjected to the higher temperature and
pressure in accordance with the present invention in batch fashion
as well. Such a first stage may be used to initiate buildup of
iodine within the resin matrix.
[0101] In accordance with the present invention an iodide-resin
demand disinfectant may, for example, be obtained by
[0102] a) bringing a porous, granular, starting resin into contact
with an aqueous sludge of iodine and potassium iodide so as to
obtain a paste mixture, iodine being present in the sludge
essentially as triiodide ions, said starting resin being a strong
base anion exchange resin having strongly basic groups thereof in a
salt form the anion of which is exchangeable with triiodide
ions,
[0103] b) subjecting the paste mixture to elevated temperature and
pressure conditions in an enclosed container or reactor (e.g.
autoclave) for a predetermined impregnating duration of time, a
void space being provided in the reactor such that contact occurs
under an (essentially) iodine (rich) atmosphere, and
[0104] c) washing the obtained iodide-resin product (with a
suitable (i.e. purity) washing liquid, (e.g. deionised water, R/O
water (at 45.degree. C.), etc.) to remove water elutable iodine
such as KI from the surface of the resin so that on drying no
iodine (KI) crystals will form on the surface of the iodine/resin;
RIO water, is water obtained using double reverse osmosis. R/O
water is defined below.
[0105] More particularly an iodide/resin demand disinfectant may be
obtained using the following sequence of steps:
[0106] 1. The resin is purified by triple passage of water and then
disposed in ethanol in an electrosonic bath and flushed with water
and drip dried;
[0107] 2. (Essentially) stoichiometric amounts of I.sub.2 and
potassium iodide are admixed with a minimum amount of water which
is just sufficient to obtain an I.sub.3- slurry or sludge (with, if
desired, very low heating);
[0108] 3. The resin is admixed with the above-minimal water slurry
in small aliquats so as to obtain a predetermined weight ratio of
slurry to resin (e.g. a 50:50 weight ratio);
[0109] 4. The resin-slurry mixture is then placed in a shaking bath
at atmospheric pressure in a closed, air-tight container (if
necessary the container being provided with a small pressure
release valve or opening the purpose of which will be hereinafter
explained) for a predetermined time period (e.g. for up to, for
example, sixteen to twenty-four hours or more [e.g. a week if
desired]) to form an intermediate resin composition;
[0110] 5. The container containing the reaction mixture is then
disposed in a (steam) autoclave and heated at high temperature,
(e.g. 120.degree. C.) to provide a super atmospheric pressure
therein (with the small valve open if the container walls would not
be able to resist the pressure to be exerted within the autoclave)
for a predetermined residence time (e.g. a residence time of about
fifteen minutes) calculated from the time the mixture reaches the
predetermined high temperature (e.g. 120.degree. C.).
[0111] 6. The autoclave is removed from the heat and as soon as the
pressure is equalized to atmospheric, the internal container is
removed and the resin product is washed (e.g. six times) with R/O
water until the wash water comes out with a total iodine content of
less than 0.1 parts per million.
[0112] A small hole is necessary when a container such as a glass
flask is used in order to avoid a too great pressure difference
being built up between the interior of the flask and the interior
of the autoclave which might cause the flask to collapse. The hole
in any event is just large enough to more or less allow for the
equalization of pressure and to maintain a positive pressure in the
flask relative to the interior of the autoclave such that any
foreign material such as water vapour is inhibited from flowing
into the flask. A more sturdy pressure resistant container could of
course be used such that, depending on the construction of the
container and the temperature/pressure conditions prevailing in the
autoclave, the hole may be avoided. Alternatively, instead of using
a separate container to hold the reaction mix and placing it in a
separate autoclave, a single autoclave/container may be used
serving to hold and heat the reaction mix under pressure; such a
container must of course be constructed so as to be able to resist
the predetermined reaction conditions.
[0113] The iodide-resin compound formed as described herein can be
used as a demand disinfectant to disinfect water by batch
contacting the contaminated water with the resin; continuous
processing as mentioned in U.S. Pat. No. 3,923,665 is also
possible. Thus water containing viable bacteria (to be killed) may
be passed through a fixed bed of porous granular iodine/resin
material. The maximum permissible flow rates for total bacterial
sterilization may vary with the concentration of the polyiodide
(e.g. triiodide) groups in the resin, bed depth, bacterial count,
etc . . . The disinfection process may be monitored by taking
samples of water after passage through the bed. Potable innocuous
water may thus be readily produced in accordance with the present
invention without the incorporation of objectionable amounts of
free iodine therein as a result. The resin may be used with any
(known) water treating devices such as for example those shown in
U.S. Pat. Nos. 4,749,484 and 4,978,449.
[0114] In accordance with a further aspect, however, as mentioned
above, the present invention also provides a method for
disinfecting air containing airborne microorganisms. The method may
comprise passing the air over a demand disinfectant resin such that
airborne microorganisms contact said resin and are devitalized
thereby, the demand disinfectant resin comprising an iodinated
strong base anion exchange resin. The method may, for example,
include passing the air through a bed of granules of iodinated
resin so that the air courses over the granules (in a serpentine
manner) as the air makes its way through the bed. The maximum
permissible flow rates for total bacterial sterilization may vary
with the concentration of the polyiodide groups in the resin, bed
depth, bacterial count, etc . . . The iodinated strong base anion
exchange resin may comprise a strong base anion exchange resin
component which represents from 25 to 90 (preferably 45 to 65)
percent by weight of the total weight of the iodinated resin.
[0115] In accordance with an additional aspect, the present
invention provides a system for disinfecting air containing
airborne microorganisms, said system, for example, comprising
[0116] means for providing an air path for the movement of air
therethrough, and
[0117] a demand disinfectant resin disposed in said air path such
that airborne microorganisms in air passing through said air path
are able to be brought into contact with said resin and be
devitalized thereby,
[0118] said demand disinfectant comprising an iodinated strong base
anion exchange resin.
[0119] An air path means may define an air inlet and an air
outlet.
[0120] The resin may be disposed between said inlet and outlet or
be disposed at the inlet or outlet. The air path means may take any
form. It may take the form of ductwork in a forced air ventilation
system with the demand disinfectant comprising a bed of resin
granules through which the air is made to pass, the bed otherwise
blocking off the air path. Alternatively the air path means may be
defined by a cartridge used for a gas mask, the cartridge having an
inlet and an outlet for air; the iodinated resin for the cartridge
may, if desired, be present as a bed of granules, granules
incorporated into a (fluid) porous carrier (e.g. tissue,
polyurethane foam, etc.) or alternatively take a more massive form
such as a plate(s), a tube(s), a block(s), etc . . . Cartridge type
gas masks are known; such gas masks may be obtained for example
from Eastern Safety Equipment Co., Mosport, N.Y., U.S.A.
[0121] The C-50 cartridge from a gas mask (from Glendale Protecting
Technologies Inc. Woodbury , N.Y., U.S.A.) may for example be
adapted to hold a bed of resin of granules of the present
invention. Referring to FIG. 3, the cartridge 1 comprises an a
hollow, open ended, thi-walled, tubular body of circular cross
section. The wall 2 may for example be of nylon. The open ends of
the cartridge are each blocked off by some suitable mesh like
support material 3 (e.g. 10 micron polypropylene mesh) which is
held in place in any suitable known manner such as by glues, spring
clip, etc. Referring to FIG. 4, the iodinated granular resin bed 4
occupies the entire space between the mesh supports 3 and 3';
although the granular resin is more or less tightly packed between
the mesh supports 3 and 3', there are still air spaces between the
granules for the passage of air through the granular bed. The mesh
supports each have openings small enough to retain the iodinated
resin in place while allowing air to pass therethrough into the and
through the supported resin bed 4. The cartridge as shown in FIG. 4
may include a downstream bed 5 of granules of activated carbon,
catalyst, or iodine absorbent resins, to scavenge any iodine
liberated from the iodinated resin 4. The activated carbon bed 5 is
held in place by a mesh support 3' and an additional mesh 6. The
bed depth of the resin and carbon is shown as about 2.5 cm; wheras
the bed diameter is about 8 cm. If the iodinated resin made in
accordance with the process of the present invention is used the
carbon bed may be omitted, i.e. only the iodinated resin bed 4 may
be present in the cartridge as the active component (in the
examples below, unless the contrary is indicated, the cartridges do
not include any carbon bed); in this case the bed depth may, for
example, be less 2.5 cm, e.g. 0.1 cm, 0.25 cm, 0.5 cm, 0.85 cm,
1.15 cm, etc . . . Such a cartridge may be disposed in an air path
as shown for example in FIGS. 5 and 6 which will be discussed
below.
[0122] The resin disposed in the air path could of course take on
any form other than granules such as blocks, plates, tubes etc . .
.
[0123] The iodinated demand disinfectant resin for air treatment
may be any (known) iodinated resin so long as the iodinated resin
is capable of devitalizing airborne microorganisms (i.e;
microorganisms transported by air) coming into contact therewith.
It may, for example, be a resin as proposed in U.S. Pat. Nos.
3,923,665 and 4,238,477; in this case, however, it may be necessary
to use the resin in conjunction with an iodine scavenging material
if the resin gives up too much iodine to the air. The iodine
scavenging material may be an activated carbon material or an
un-iodinated strong base anion exchange resin as described
herein.
[0124] Alternatively, as mentioned above, iodinated resin may
advantageously be a resin made in accordance with the present
invention; in this case the resin need not be used in conjunction
with an iodine scavenging material such as a (known) exchange
resin, activated carbon, catalyst, etc., since an iodinated resin
made in accordance with the process of the present invention may
liberate iodine into the air in an amount below acceptable
threshold limits for breathing by human beings.
[0125] If desired the iodinated resin for the treatment of air or
water may be some type of mixture of iodinated resins, e.g. a
mixture of a known iodinated resin and an iodinated resin prepared
in accordance herewith.
[0126] As mentioned above, the present invention in a further
aspect provides a combination which may act as a sterilization
barrier with respect to microorganisms. The sterilization
combination may, for example, be incorporated into protective
wearing apparel or be configured as a sterilization dressing for
lesions such as for example, wounds and burns; the sterilisation
barrier combination can be configured to be or not to be air
breathable.
[0127] A sterilization dressing of the present invention
advantageously may take the form of a flexible porous cellular
polymeric foam sheet having a spongy aspect and having dispersed
within the polymeric matrix thereof particles of a demand
disinfectant comprising a (known) iodinated resin or an iodinated
resin as described herein. The sterilization sheet may be placed
over a burn area to maintain the burn area in a sterilized state
during the healing process. The disinfectant particles are
distributed throughout the polymeric matrix and have surfaces
projecting into the open pores of the spongy matrix; the spongy
matrix acts as a sponge so that on the body side thereof it can
soak up fluid such as pus which exude from the burn lesion. Once
within the body of the matrix any microorganisms in the fluid or
pus can contact the disinfectant resin particles and become
devitalized as a result. On the other hand, any microorganisms on
the opposite side of the sterilization barrier which attempt to
pass through the barrier are also subject to being contacted with
the disinfectant and are also devitalised.
[0128] A (flexible) phamaceutically acceptable hydrophilic foam
matrix may be obtained by reacting water with HYPOL foamable
hydrophilic polyurethane polymer; the HYPOL polymer starting
material may be obtained from W. R. Grace & Co. Lexintington
Mass. U.S.A. Water reacts to cross link the HYPOL polymer; if water
is added quickly or at relatively high temperature foaming occurs
and a foam product is obtained.
[0129] The carrier component may, as necessary, also be oil or fat
loving, e.g. for dealing with individuals with high cholesterol
levels.
[0130] If desired the iodinated resin for the sterilisation
combination may be some type known iodinated resin, a resin
prepared in accordance herewith, or a mixture of iodinated resins,
e.g. a mixture of a known iodinated resin and an iodinated resin
prepared in accordance herewith.
[0131] FIGS. 7 to 11 which illustrate a number of example
embodiements of sterilisation barrier combinations of the present
invention will be discussed below; these combinations are also
described in example 15 below.
[0132] Turning back to the process of the present invention, if
commercially available materials are to be used to make the
iodine/resin then, depending on the purity thereof, the starting
materials may have to be treated to remove components which may
interfer with the absorption of the halide into the resin. Water if
present in the initial reaction mix should be free of interfering
elements such as interfering ions. Distilled or ion free water is
preferably used for washing.
[0133] The following materials may be used to prepare a triiodide
resin in accordance with the present invention:
[0134] a) Amberlite 401-S (from Rohm & Hass) a strong base
anion exchange resin in granular form, having the following
characteristics:
[0135] support matrix--styrene/divinyl benzene polymer
[0136] anion--chlorine
[0137] density--1.06
[0138] effective size (diameter)--0.52 mm
[0139] total exchange capacity--0.8 meq/ml
[0140] working Ph range--0 to 11
[0141] moisture content--62%
[0142] working temperature--170.degree. F. or less
[0143] b) I.sub.2 (solid)--U.S.P. grade (from Fisher
Scientific)
[0144] c) Potassium iodide (KI)--U.S.P. grade (from Fisher
Scientific)
[0145] d) Water--ultra pure: obtained using double reverse osmosis
(i.e. herein sometimes-referred to simply as R/O water)
[0146] e) Ethanol--U.S.P. grade (from Fisher Scientific)
[0147] Using the above substances a resin cramed with triiodide
(i.e. a triiodide jam-backed resin) may be obtained as indicated in
the following examples.
[0148] For the following examples, the following procedure for the
evaluation of iodine (I.sub.2) and Iodide (I.sup.-), was conducted
according to "standard methods for the examination of water and
wastewater 17e Ed.":
[0149] Iodine method: mercuric chloride added to aqueous elemental
iodine solutions causes complete hydrolysis of iodine and the
stoichiometric production of hypoiodous acid. The compound 4, 4',
4" methylidynetris (leuco crystal violet) reacts with the
hypoiodous acid to form crystal violet dye. The maximum absorbance
of the crystal violet dye solution is produced in the Ph range
3.5-4.0 and measured at a wavelength of 592 nm. The absorbance
follows beers' law over a wide range of iodine concentration.
Iodine can be measured in the presence of max. 50 PPM iodide ions
without interference.
[0150] Iodide method: iodide is selectively oxidized to iodine by
the addition of potassium peroxymonosulfate. The iodine produced
reacts instantaneously with the indicator reagent leuco crystal
violet over the same conditions described previously for iodine
methods. Total iodine+iodide results from this procedure and iodide
is calculated from substraction of iodine concentration.
[0151] Readings were performed on a lkb spectrophotometer with a
lightpath of 1 cm and selected at 592 nm.
EXAMPLE 1
[0152] STARTING MATERIALS PRETREATMENT:
[0153] i) Resin:
[0154] The resin is water washed to remove undesirable elements
such as material in ionic form. Thus, 100.00 grams of Amberlite 401
S and 200 ml of R/O water are placed in an erlenmyer of 1000 ml.
The mixture is shaken for about 3 minutes and the water is then
separated from the resin by drip filtration using a wathman filter
paper and funnel. The resin is water washed in the same fashion two
more times. After the last water wash the resin is drip dried (i.e.
again using a wathman filter paper and funnel) for 15 minutes.
[0155] The so recovered water washed resin is subjected to an
alcohol wash to dissolve undesirable organic material which may be
stuck on the resin. Thus, the water washed resin is immersed in
300.00 ml of ethanol. The resin alcohol mixture is shaken in an
ultrasonic bath (Crest ultrasonic:1000 Watts--20 liter capacity)
for 5 minutes. The alcohol washed resin is drip dried, again using
a wathman filter paper and funnel.
[0156] The "fish" smell is removed from the alcohol washed resin by
a final water washing stage wherein the wash R/O water is preheated
to 40 degrees celsius. The alcohol washed resin is placed in an
erlenmyer flask (1000 ml) and 250 ml of R/O water at 40 degrees
celsius is added thereto. The water-resin mixture is shaken in a
shaking bath (Yamata shaking bath--1 impulse per second/water at 32
degrees celsius) for 5 minutes; the water is then removed from the
resin by drip drying as mentioned above. The water wash is repeated
once more and the resin is drip dried (for 1 hour) as mentioned
above. The washed resin is now ready for use in example 2
hereinbelow.
[0157] ii) Iodine sludge containing water:
[0158] A mixture of iodine (I.sub.2) and potassium iodide (KI) is
prepared by mixing together, in an erlenmyer flask, 60.00 grams of
iodine and 40.00 grams of potassium iodide (in both cases on a dry
weight basis). Thereafter R/O water is admixed slowly drop by drop
with the mixture until a metallic looking sludge is obtained (e.g.
with the addition of about 5.00 grams of water). The obtained
iodine/potassium iodide sludge is then ready for use in example 2
hereinbelow.
EXAMPLE 2
[0159] LOW TEMPERATURE/PRESSURE PREIMPREGNATION OF RESIN WITH
IODINE
[0160] The aqueous iodine sludge, as obtained above, is placed in a
500.00 ml Erlenmyer flask and is slowly heated to, and maintained
at 40 degrees celsius for a few minutes. Once the temperature of
the sludge reaches 40.degree. C., the washed resin, obtained as
above, is slowly admixed with the iodine sludge in 10.00 gram
portions every 8 minutes until all of the washed resin is within
the erlenmyer flask. The 500 ml Erlenmyer flask, containing the
obtained starting mix (comprising the I.sub.2/KI mixture and the
washed resin--approximately 100 grams of each of the starting
materials), is then sealed with a cork and is placed in a shaking
water bath (Yamato BT:-25) for a period of 16 hours. The
temperature of the water in the shaking bath is maintained at about
20 degrees celsius during this time period. At the end of the time
period, the Erlenmyer flask is removed from the shaking bath; at
this point the removed flask contains an preimpregnation mix
comprising impregnated resin and remaining I.sub.2/KI. The
Erlenmyer flask is sized such that at the end of this (initial)
impregnation step, it is only 50% filled with the in process resin,
etc, i.e. there is a void volume above the impregnation mix.
[0161] NOTE: If processing of the treated resin is stopped at this
point and the obtained resin is suitably washed, a resin is
obtained in accordance with the prior art i.e. U.S. Pat. No.
3,923,665.
EXAMPLE 3
[0162] ELEVATED PRESSURE/TEMPERATURE TREATMENT
[0163] The cork of the Erlenmyer flask of EXAMPLE 2 removed from
the shaking bath and including the obtained impregnation mix
comprising impregnated resin and remaining I.sub.2/KI, is changed
for a cork having a small diameter perforation passing therethrough
(i.e. of about 3 mm in diameter). With the perforated cork in
place, the Erlenmyer flask is disposed within a (steam pressure)
autoclave along with a suitable amount of water. With the autoclave
(pressure) sealed about the flask, the autoclave is heated. Heating
proceeds until an internal temperature and pressure of 115 degrees
Celsius and 5 psig respectively is reached. Once those parameters
have been reached, they are maintained for 15 minutes of processing
time. Thereafter the autoclave is allowed to slowly cool for 50
minutes of cooling time (until the internal pressure is equal to
ambient pressure) before removing the Erlenmyer flask containing a
(raw) product resin demand disinfectant in accordance with the
present invention.
EXAMPLE 4
[0164] WASHING OF RAW PRODUCT RESIN
[0165] The (raw) disinfectant of Example 3 is removed from the
autoclave Erlenmyer flask and placed in another 2000 ml Erlenmyer
flask. 1400 ml of R/O water at 20 degrees Celsius is admixed with
the resin in the flask and the slurry is shaken manually for 3
minutes. The wash water is thereafter removed from the flask by
decantation. This wash step is repeated 7 more times. The entire
wash cycle is repeated twice (i.e. eight water washes per cycle)
but using water at 45 degrees Celsius for the next wash cycle and
then with water at 20 degrees Celsius for the last wash cycle. The
washed iodine-resin is then ready to use.
EXAMPLE 5
[0166] COMPARATIVE PHYSICAL DATA
[0167] The following resins were examined with respect to certain
physical characteristics:
[0168] Resin I-A:
[0169] Iodinated resin manufactured in accordance with the present
invention i.e. as obtained from example 4 above.
[0170] Resin I-B:
[0171] Iodinated resin manufactured in accordance with teachings of
the prior art (i.e. U.S. Pat. No. 3,923,665), namely as obtained
from example 2 above after suitable washing to remove elutable
iodine.
[0172] Resin I-C:
[0173] Iodinated resin manufactured by Water Technology Corporation
in Minneapolis (a triiodide based disinfectant resin).
[0174] Resin I-D :
[0175] Iodinated resin manufactured by Water Technology Corporation
in Minneapolis, sold under the Trademark: Pentapure.
[0176] In the examples which follow the above resins will be
referred to using the above designations, i.e. I-D, Resin I-A,
etc.
EXAMPLE 5.1
[0177] COMPARATIVE WET TAP DENSITY:
[0178] The resins were examined in a drip dried state, i.e. the
resins were used after being drip dried using wathman filter paper
and a funnel (for a 5 minute dry period). 25 ml and 100 ml flasks
were used for the study. The flaskes were weighed empty. The flasks
were then filled with resin and were then subjected to a manual
vibration sequence (approximately 2 impulses per second for two
minutes) in order to settle the resin, the volume of the settled
resin was then noted. The density was obtained by weighing a filled
flask and subtracting the weight of the empty flask so as to obtain
the weight (grams) per unit volume (ml) of the resin. The results
are shown in Table 1 below.
1 TABLE 1 Resin density I-A 1.720 gm/ml I-B 1.480 gm/ml I-D 1.600
gm/ml
EXAMPLE 5.2
[0179] COMPARATIVE DRY TAP DENSITY:
[0180] The same procedure as described above for example 5.1 was
used except that the initial resin materials were dried
simultaneously for 12 hours at 55 degrees Celsius, and placed in
desiccant for 2 hours during cooling. The results are shown in
Table 2 below.
2 TABLE 2 Resin Density I-A 1.088 gm/ml I-B 0.957 gm/ml I-D 1.016
gm/ml
EXAMPLE 5.3
[0181] IODINE CONTENT:
[0182] 1.0 gm of each of the different resins was boiled in 20 ml
of water with a concentration of 5% by weight of sodium
thiosulphate. Boiling was conducted for 20 minutes whereafter the
water mixture was set aside to air cool for 12 hours. The resin was
then recovered and washed with 50 ml of a boiling water solution of
sodium thiosulphate. Thereafter the resin was dried in an oven for
12 hours at 105 degrees. The iodine desorbed resin was weighed in
each case and the weight difference was used to calculate the % by
weight of the initial resin represented by the active iodine
removed. The results are shown in Table 3 below.
3 TABLE 3 Resin % by weight iodine I-A 43.7% I-B 32.4% I-C 30.7%
I-D 36.7% NOTE: As may be seen from Table 3, the resin in
accordance with the present invention (i.e resin I-A) has a
substantially higher iodine content than the commercially available
resins or the resin prepared in accordance with the prior art (i.e.
resin I-B).
EXAMPLE 5.4
[0183] COMPARATIVE IODINE CONTENT IN WATER DURING STAGNATION:
[0184] 100.00 gm of each resin was mixed with 125 ml of water in
Erlenmyer flask which was sealed airtight. -The water mixture was
allowed to stand 20 degrees Celsius for 7 days. A water sample was
then taken from each water mixture and subjected to a standard
method for testing water for the presence of Iodine using the Leuco
Crystal Violet lodometric Spectrophotometer Technique so as to
obtain the "ppm" concentration of iodine in the water. The results
are shown in Table 4 below.
4 TABLE 4 Resin bleed iodine concentration (ppm) I-A 1.7 ppm I-D
2.5 ppm NOTE: As may be seen from table 4, the resin of the present
invention (resin I-A) has a significantly lower iodine bleed lose
into water than the commercial product (resin I-D).
EXAMPLE 5.5
[0185] RESIN SIZE STUDY:
[0186] Two grams of dry resin was examined with a microscope having
a micrometer scale system and sized by eye. The results are shown
in Table 5 below.
5 TABLE 5 Size (i.e. approximate effective Resin diameter
size)-lowest to highest AMBERLITE I 401 S 0.35 mm to 0.52 mm I-A
0.60 mm to 1.20 mm I-B 0.40 mm to 1.00 mm
EXAMPLE 6
[0187] Simultaneous tests were conducted to compare the
antimicrobial activity of a disinfectant resin in accordance with
the present invention (resin I-A, above) and a prior art
disinfectant resin (resin I-D, above). A series of batch solutions
was prepared; each batch solution contained a different
microorganism. A batch solution was divided into test portions so
that the comparative tests could be carried out against each of the
resins at the same using a respective test portion of the batch
solution; the volume of the test portions was 150 liters. The same
amount of each of the resins was supported in a respective fixed
bed configuration (i.e. the resins were disposed in a cylinder 1 cm
high having an internal diameter of 3 cm). The respective test
solutions were allowed to pass downwardly through each of the
resins in the same fashion and at the same flow rate (i.e. the test
conditions were the same for each resin). The tests were carried
out at ambient conditions of temperature and pressure. The
microorganisms and test results were as follows:
[0188] a) A lyophilized strain of KLEBSIELLA TERRIGENA (A.T.C.C.
33257) was rehydrated in phosphate-buffered saline (PBS) and was
subcultivated in order to obtain a broth with a bacterial density
of 10.sup.9 cfu/ml (cfu=colony forming units). The broth was
treated to obtain media free monodispersed bacterial cells. The
bacterial solution was then diluted in water to provide the test
batch solution at an initial concentration of 4.8.times.10.sup.7
cfu per 100 ml.
[0189] Microbiological monitoring of the test water was done
throughout the experiment. Sampling of the filtered water was done
at intervals prescribed by the: U.S.E.P.A. (protocol section 3.5.1
d 1(b)) with the membrane-filter technique for KLEBSIELLA described
in: 17th edition of Standard Methods for the examination of water
and wastewater, pp. 9-97 to 9-99.
[0190] A test solution containing KLEBSIELLA TERRIGENA (A.T.C.C.
33257) at an initial concentration of 4.8.times.10.sup.7 per 100 ml
was passed through the fixed bed of each resin at a flow rate of
125 ml/min to 200 ml/min. The treated volume of solution for each
resin was 150 liters in total. Sampling of the effluent or treated
solution was effected at intervals corresponding with a
predetermined percentage of the test portions having passed through
the resins. The results are shown in Table 6a below:
6TABLE 6A Total % of test Microorganism concentration in test
solution passed effluent for each resin type (cfu/ml) through the
resin Resin I-D Resin I-A 0% 0/0/0 0/0/0 25% 0/0/0 0/0/0 50% 0/0/0
0/0/0 60% 0/0/0 0/0/0 75% 0/0/0 0/0/0 90% 0/0/0 0/0/0 100% 0/0/0
0/0/0
[0191] As may be seen from table 6a the destruction of the bacteria
was total in the case of each resin.
[0192] b) Poliovirus 1 (A.T.C.C VR-59) was obtained as a lypholized
pellet, rehydrated in PBS, and grown on buffalo green monkey (BGM)
kidney cells from the Armand Frappier Institute (IAF) in Laval
Quebec. Standard cell culture and virological procedures were used
to obtain a concentration of 3.times.10.sup.7 of monodispersed
virion particles per ml. Enough virus was added to a holding tank
to obtain a concentration of about 1.times.10.sup.7 pfu per liter
for the test batch solution (pfu=plaque-forming units).
[0193] The assay technique consisted of inoculating healthy BGM
cells with a small amount of filtered water at regular intervals.
If a virus particle were present, a plaque would be observed on the
cellular bed thru the gellified maintenance media which contained a
vital stain.
[0194] A test solution containing Poliovirus 1 (A.T.C.C VR-59) at
an initial concentration of 1.times.10.sup.7 pfu per liter was
passed through the fixed bed of each resin at a flow rate of 125
ml/min to 200 ml/min. The treated volume of solution for each resin
was 150 liters in total. Sampling of the effluent or treated
solution was effected at intervals corresponding with a
predetermined percentage of the test portions having passed through
the resins. The results are shown in Table 6b below:
7TABLE 6B Total % of test Virus concentration in test effluent
solution passed for each resin type (pfu/l) through the resin Resin
I-D Resin I-A 0% 0/0/0 0/0/0 25% 0/0/0 0/0/0 50% 0/0/0 0/0/0 60%
0/0/0 0/0/0 75% 0/0/0 0/0/0 90% 0/0/0 0/0/0 100% 0/0/0 0/0/0
[0195] As may be seen from table 6b the destruction of the
Poliovirus was total in the case of each resin.
[0196] c) Rotavirus (A.T.C.C VR-899) was obtained , rehydrated in
PBS, and grown on A-104 cells obtained from IAF. The method used to
obtain the diluted poliovirus above was used with respect to the
rotavirus. The yield for rotavirus grown on MA-104 cells was
2.times.10.sup.6 pfu/ml. After dilution in the holding tank the
concentration of the virus was 1.times.10.sup.7 pfu per liter.
[0197] The assay techniques were similar to those used for
poliovirus, only the cell type and vital stain changed since they
are specific for each type of virus. The same sampling strategy was
applied.
[0198] A test solution containing Rotavirus (A.T.C.C VR-59) at an
initial concentration of 1.times.10.sup.7 per 100 ml was passed
through the fixed bed of each resin at a flow rate of 125 ml/min to
200 ml/min. The treated volume of solution for each resin was 150
liters in total. Sampling of the effluent or treated solution was
effected at intervals corresponding with a predetermined percentage
of the test portions having passed through the resins. The results
are shown in Table 6c below:
8TABLE 6C Total % of test Virus concentration in test effluent
solution passed for each resin type (cfu/ml) through the resin
Resin I-D Resin I-A 0% 0/0/0 0/0/0 25% 0/0/0 0/0/0 50% 0/0/0 0/0/0
60% 0/0/0 0/0/0 75% 0/0/0 0/0/0 90% 0/0/0 0/0/0 100% 0/0/0
0/0/0
[0199] As may be seen from table 6c the destruction of the
Rotavirus was total in the case of each resin.
EXAMPLE 7
[0200] An iodine bleed test was conducted on the Resin I-A and
Resin I-D mentioned above. The tests were conducted as follows:
[0201] A pressure syringe was filled with 20 grams of resin (inner
chamber of 3 cm.times.13 cm). Using a peristaltic pump 750 ml/min
of R/O water (sterilized) was pumped through the syringe; the resin
being maintained in the syringe by suitable mesh means. The total
water passed through the resin was 5 liters.
[0202] The results of the tests are given in the graph shown in
FIG. 1; i.e. ppm iodine in effluent vs total volume water passed
through resin. The bleed test results as shown in the graph
compares iodine (I.sub.2) and iodide (I.sup.-) in effluent of
treated water after passing through each of the resins.
EXAMPLE 8
[0203] The bacteriocidal longevity of the Resin I-A and Resin I-D
were determined for purposes of comparison. Two fixed resin bed
devices were provided, one device loaded with one of the resins and
the other device loaded with the other resin; each device was
loaded with 75.00 grams of a respective resin. The tests for each
resin bed were conducted simultaneously. For each resin bed, the
solution to be treated was passed therethrough at a flow rate of
2.0 litres per minute, with an initial concentration of Klebsiella
Terrigena 1.times.10.sup.7 cfu/10 ml. The effluent was tested at
intervals for the presence of viable bacteria. As may be seen in
the graph of FIG. 2, the volume of contaminated solution at which
bacteria start to pass through the prior art resin (i.e. Resin I-D)
is significantly less than the breakthrough volume for the resin of
the present invention (i.e. Resin I-A). From FIG. 2 it may be seen
that the bacteriocidal activity of the disinfectant resin of the
present invention (Resin I-A) is superior to that of the known
resin (Resin I-D), i.e. the Resin I-A has about a 16% superior
antimicrobial activity in relation to the amount of water treatable
by a given amount of disinfectant resin.
EXAMPLE 9
[0204] Preparation of Resin I-A' of the present invention
[0205] An iodinated resin (Resin I-A') was prepared following the
procedures of examples 1 to 4 except that for the resin, Amberlite
IR-400 (OH.sup.-) (was used and for the procedure of example 3 the
elevated temperature and pressure conditions were set at
121.degree. C. and 15 psig respectively. Resin I-A' was used in the
following examples.
EXAMPLE 10
[0206] COMPARATIVE IODINE CONTENT IN EFFLUENT AIR
[0207] Two cartridges as illustrated in FIGS. 3 and 4 were
prepared. Each cartridge contained 50.0 grammes of dry (granular)
resin (i.e. and no activated carbon bed). One cartridge contained
Resin I-A' and the other contained Resin I-D.
[0208] The cartridges were each disposed in a system as illustrated
in FIG. 5 but which did not contain any atomizer indicated
generally by the reference number 7. The system included a housing
8 for defining an air path and had an air inlet 9. The resin
cartridge I was disposed at the outlet of the air path. The air
leaving the cartridge 1 was directed by appropriate tubing to a
collector station 10. The system included a vacuum pump 11 (but not
the air sterilizer system 12) for drawing air from inlet 9 through
the system.
[0209] In operation a cartridge 1 was releasably placed in position
(e.g. snap fit, etc.) and the vacuum pump activated so as to draw
outside air (indicated by the arrow 13) into the housing 8. The air
passed through the cartridge 1 as shown by the arrows 14. The air
leaving the cartridge 1 was then directed to the collector station
10. The air entering the collector station 10 impinged upon a
iodine collector solution 15 (comprising double reverse osmosis
water, i.e. R/O water) in the collector station 10. Air leaving the
collector station 10 thereafter passed through the pump 11 and was
exhausted to the outside air.
[0210] Using the above described system, each, cartridge was
submitted to an air velocity therethrough of 0.7 Liter/per minute
for a period of 50 minutes. The collector station 10 included 50 ml
purified R/O water (the water was then subjected to standard
optical coloration techniques (i.e. the Leuco violet technique as
referred to in example 5.4 above), to determine the total iodine
content).
[0211] The results of the tests are shown in table 10a:
9 TABLE 10A Resin type total iodine (I.sub.2) Resin I-A' 0.4 ppm
Resin I-D 1.1 ppm
[0212] The results of the tests as shown in table 9a means that
each gramme of both of the resin types will add a definite amount
of iodine to the effluent air, namely as indicated in table
10b.
10 TABLE 10B Resin type iodine (I.sub.2) release per gram resin
Resin I-A' 0.014 Mg/m.sup.3/gr Resin I-D 0.031 Mg/m.sup.3/gr
[0213] Thus, for example, if a gas mask cartridge as discussed
above contained 50.0 gm of iodinated resin, the resins would emit
the level of iodine set out in table 10c below
11 TABLE 10c Resin type iodine (I.sub.2) release Resin I-A' 0.7
Mg/m.sup.3 (= 50 gr .times. 0.014 mg/m.sup.3/gr) Resin I-D 1.5
Mg/m.sup.3 (= 50 gr .times. 0.031 mg/m.sup.3/gr)
[0214] The "Committee of the American conference of governmental
industrial hygienist." emits the "threshold limit value" or T.L.V.
for common chemicals. The iodine T.L.V. is 1.0 Mg/m.sup.3 for air
analysis for human breathing during a period of 8 hrs.
[0215] Thus, while the Resin I-D releases 50% more iodine than the
maximum T.L.V. indicated above, the Resin I-A' (of the present
invention) releases iodine at a level well below the T.L.V. The
Resin I-A' could thus be used without an iodine scavenger; this
would, for example, simplify the construction of a gas mask
cartridge. The known Resin I-D on the other hand could also be used
but it would require some sort of iodine scavenger (e.g. activated
carbon) to obtain the necessary iodine T.V.L. level.
EXAMPLE 11
[0216] The Resin I-A' was tested with different micro-organisms
under different conditions for the sterilization of air.
EXAMPLE 11.1
[0217] Direct contact sterilization study
[0218] Resin I-A' was evaluated for its biocidal capacity on direct
contact with Klebsiella Terricena in relation to a time reference
and a humidity content variation; namely water content variations
of 110%, 50% & 0% (relative to the weight of dry resin) and
time variations of 2, 5, 10, and 15 seconds.
[0219] After preparing the three resins with their respective
humidity content 25 glass rods were sterilized. A vial containing
25 ml of the inoculum (Klebsiella Terrigena: 10.sup.9.times.ml) was
also prepared.
[0220] The testing proceeded as follows with respect to the dry
resin. A glass rod was immersed in the inoculum and then immersed
in the dry resin for 2 seconds. The glass rod was then washed in
100 ml phosphate buffer to wash out the microorganisms. Following
the standard method for evaluation of water, the collected sample
was then plated and incubated. This procedure was then repeated for
5, 10 and 15 seconds.
[0221] The procedure was also repeated for the two other different
humidity content batches of Resin I-A'. The results of the test are
shown in table 11a.
12 TABLE 11a number of viable microorganisms per time period %
humidity 2 sec. 5 sec. 10 sec. 15 sec. 110% 16 0 0 0 50% 23 1 0 0
0% 67 15 0 0
[0222] As may be seen from table 11a, the Resin I-A' whether wet,
humid or dry destroys large quantities of resistant bacteria in
direct contact, and this destruction occurs on a relatively rapid
time base as demonstrated above.
EXAMPLE 11.2
[0223] KLEBSIELLA TERRIGENA ERADICATION STUDY: AIR FLOW.
[0224] A study was done to evaluate the biocidal effectiveness of
dry Resin I-A' versus Klebsiella Terrigena.
[0225] The system used was the system illustrated in FIG. 5. The
system included an atomizer 7 (of known construction) disposed in a
housing 8 provided with an air opening 9. The system had a vacuum
pump 11 for the displacement of air through the system. The system
included an air sterilizer 12 comprising a hollow housing 10 inches
high by about 2.5 inches in inner diameter and filled with about
1.5 kilograms of Resin I-A'; the sterilizer has an air inlet and
outlet. The air path through the cartridge 1 is designated by the
arrows 14. The atomizer 7 contained an inoculum 16 (Klebsiella
Terrigena: 10.sup.7.times.100 ml). For the test, the air flow at
arrow 13 was set at 30 liters per minute and the air inflow at
arrow 17 for the atomizer was set at 8 liters per minute; the
atomizer 7 injected mist or spray 18 of inoculum into the air in
the air path and the inoculated air then passed through cartridge 1
as shown by the arrows 14.
[0226] A cartridge 1 as illustrated in FIGS. 3 and 4 was prepared
using dry Resin I-A' (65.0 gm giving a bed depth of 1.15 cm). The
cartridge 1 was submitted to an injection of a total of 10 ml of
inoculum over a time period of 15 minute. Sampling was done at 0
minutes, 7.5 minutes and at 15 minutes. The samples were collected
in a standard impinger as shown in FIG. 5. After, processing 100 ml
of the water from the impinger on microbiological paper filter and
incubation, the results show total eradication of Klebsiella
Terrigena.
EXAMPLE 11.3
[0227] BACILLUS PUMILUS ERADICATION: AIR CONTACT.
[0228] A study was carried out using the system shown in FIG. 6. To
the extent that members of the system are the same as those used in
the system illustrated in FIG. 5, the same reference numerals are
used to identify the same parts. The main difference between the
system of FIG. 5 and that of FIG. 6 is that the system of FIG. 6
uses a microbiological filter paper 19 to collect the
microorganisms leaving the cartridge 1; the filter paper is
maintained in place in any (known) suitable fashion.
[0229] An inoculum 20 of the thermophilic bacteria Bacillus Pumilus
was prepared and injected at a concentration of 10.sup.3/litre of
influent air. A cartridge mask containing 65.00 gm of Resin I-A'
was prepared as for the previous example. The test ran for 30
minutes.
[0230] All effluent (velocity at arrow 13 being 30 litres per
minute) was collected on the microbiological filter paper 19 (from
millepore), then lain in a T.S.A. (trypticase Soy Agar) and
incubated the results showed total eradication of Bacillus
Pumilus.
EXAMPLE 11.4
[0231] BACILLUS SUBTILIS STERILIZATION IN AIR FLOW.
[0232] This test was performed with Bacillus Subtilis in a mixture
of 40% active bacteria/60% spores. The system shown in FIG. 6 was
used with the cartridge comprising 50 grams of Resin I-A' (giving a
bed depth of 0.85 cm). The controlled concentration of processed
air was 55 bacteriological units per litre. The air velocity was 23
litre per minute for 80 minutes.
[0233] Once the 80 minutes ended, the millepore filter paper was
collected, lain on T.S.A. (after neutralisation of potential iodine
with sodium thiosulfate 5%) and incubated for 48 hours at 37 degree
celsius. The results show a total eradication of
micro-organisms.
EXAMPLE 11.5
[0234] BACILLUS SUBTILIS: Resin I-A' versus glass beads in air
flow.
[0235] In order to assess the retention factor of micro-organisms
on inert materials this test was performed. Also, to evaluate the
migration factor of the biological vector, a sequential incubation
was performed.
[0236] Two gas cartridges were built in accordance with FIGS. 3 and
4, namely:
13 a) Resin I-A' cartridge 10 micron polypropylene upstream mesh
(filter); 50.00 gm of Resin I-A' giving a bed depth of .85 cm; 10
Micron polypropylene downstream mesh (filter). b) Glass bead
cartridge 10 micron polypropylene upstream mesh (filter); 50.0 gm
sterile glass beads (from Fisher Scientific and having the same
size as the beads of Resin I- A') giving a bed depth of .85 cm; and
10 Micron polypropylene downstream mesh (filter).
[0237] The system as shown in FIG. 6 was used for the tests.
[0238] Simultaneously, the two cartridges were, once inserted in
their respective testing chamber, submitted to a velocity of 23
litre per minutes for 40 minutes with a microbiological load of 40
bacteria per litre in the influent.
[0239] Once the test period completed, the two cartridges were
dissected in sterile conditions and the microbiological filter
paper recovered. Each materials composing the masks were
individually as well as the filter paper were incubated in T.S.A.
for 48 hours at 37 degree Celsius. The results are shown in table
11b.
14 TABLE 11b Resin I-A' Glass beads upstream mesh: 2 cfu tnc* cfu
Resin.backslash.beads: 0 cfu tnc* cfu downstream mesh: 0 cfu 220
cfu microbiological 0 cfu 86 cfu filter paper: *tnc =
microorganisms too numerous to count
[0240] As may be seen from table 11b the Resin I-A' eradicated all
bacteria and no living micro-organism can live in the resin
bed.
[0241] The Glass beads on the other hand have a mechanical
filtering capacity in regards to the biological vector but
migration occurs rapidly thus obtaining "tnc" results (too numerous
to count) on the upstream mesh and the beads themselves. The
migration keeps on going through the filter until it reaches the
microbiological paper filter in large number. Also, the glass beads
filter becomes severely contaminated, causing a disposal
problem.
EXAMPLE 11.6
[0242] BACILLUS SUBTILIS: Resin bed depth comparison This test was
performed to establish the biocidal effectiveness of the Resin I-A'
in regards to the microbiological eradication of Bacillus Subtilis.
The system of FIG. 6 was used.
[0243] Two cartridges as illustrated in FIGS. 3 and 4 containing
respectively 30.00 gm (giving a bed depth of 0.5 cm) and 50.00 Gr
(giving a bed depth of 0.85 cm) of Resin I-A were submitted to 60
minutes of air pumping at a velocity of 27 litre per minutes. A
total of 23 ml of inoculum at a concentration of 10.sup.7 per ml
were injected into the system.
[0244] A positive control yielded a concentration of 275 cfu/litre
of air at the microbiological sampling site.
[0245] The results show total eradication for both cartridges.
EXAMPLE 11.7
[0246] BACILLUS SUBTILIS: LONGEVITY STUDY IN AIR FLOW.
[0247] A cartridge of FIG. 3 and 4 containing 30. 00 gr (bed depth:
0.5 cm) of Resin I-A' was submitted to an air flow velocity of 25
litre/minute containing a concentration of Bacillus Subtilis of 112
cpu/litre (positive control for correlation) for a period of 3
hrs.
[0248] The test was done using the impinger technique (of FIG. 5),
with 300 ml of sterile water. Once the 3 hours completed the water
from the impinger was filtered on a microbiological membrane as
referred in standard method for analysis of water and waste water
17th edition, pp.9-97 To 9-99. The growth media was trypticase soy
agar. The results after incubation for 48 hours at 37.5 degree
celsius was total eradication.
EXAMPLE 12
[0249] Studies of the fixation of iodine at different iodine
concentrations
[0250] Resin I-A', Resin I-B', Resin I-B" and Resin I-A" were
prepared as follows:
[0251] Resin I-A' was prepared as described in example 9.
[0252] Resin I-B' was prepared following the procedures of examples
1 and 2 except that for the resin, Amberlite IR-400 (OH.sup.-)
(from Rohm & Hass) was used.
[0253]
[0254] Resin I-B" was prepared following the procedures of examples
1 and 2 (using Amberlite 401-S) except that the amount of the
I.sub.2/KI mixture was adjusted so as to provide a resin comprising
about 30 percent iodine at the end of the procedure in example 2;
the mixture obtained at the end of the procedure of example 2 was
divided into two equal parts and one part was subjected to a wash
to provide the iodinated resin obtained as at the end of the
procedure in example 2; and
[0255] Resin I-A" was prepared by taking the remaining one half
part of the intermediate mixture obtained in the preparation of
Resin I-B" (mentioned above) and subjecting the mixture to the
procedure of example 3 except that the elevated temperature and
pressure conditions were set at 121.degree. C. and 15 psig
respectively.
[0256] The iodine content of the above iodinated resins was
determined in accordance with the procedure outlined in example
5.3. The resins were also subjected to an iodine bleed test as
outlined in example 7. The results are shown in table 12 below:
15TABLE 12 Resin type Iodine % Iodine leach Resin I-B' 43.5 0.15
ppm Resin I-A' 41.8 0.05 ppm Resin I-B" 30.5 0.3 ppm Resin I-A"
29.0 0.05 ppm
[0257] As may be seen from table 12, subjecting the resin to a high
temperature/pressure treatment results in the iodine being more
tenaciously fixed to the resin at different iodine
concentrations.
EXAMPLE 13
[0258] Air study with I-B"
[0259] The procedure of example 11.6 was followed using 30 grams of
Resin I-B" and Bacillus Subtilis at a concentration of 275000 cfu
per cubic meter. It was found that the Resin I-B" eradicated only 7
to 10% of the microorganisms. The results of the test show that the
Resin I-B" is not as effective at eradicating microorganisms from
air as is the Resin I-A'; it would be necessary to have
substantially more of Resin I-B" in order to totally sterilize air
as compared with the Resin I-A'.
EXAMPLE 14
[0260] Studies of the fixation of iodine at different temperatures
as well as at atmospheric and elevated pressures
[0261] Resin 1A, Resin 2B, Resin 3A and Resin 4B were prepared as
follows:
[0262] The starting resin was Amberlite 402 (OH.sup.-) from Rohm
& Hass. 1000 grams of this resin was pretreated following the
procedure outlined in example 1(i). The obtained washed resin was
divided into four 200 gram portions. An iodine sludge (four
portions, one for each of the above mentioned 200 gm portions of
resin) was prepared as outlined in example 1(ii) but using twice
the amount of materials such as the iodine and the potassium
iodide. The 200 gm resin portions were each iodinated using a
respective iodine sludge as follows:
[0263] Resin 1A was prepared, using an above mentioned 200 gm resin
portion and a respective iodine sludge, following the procedures of
examples 2 to 4 except that for the procedure of example 3 the
elevated temperature and pressure conditions were set at
121.degree. C. and 15 psig respectively (while the reaction time at
the elevated conditions remained at 15 minutes);
[0264] Resin 2B was prepared, using an above mentioned 200 gm resin
portion and a respective iodine sludge, following the procedure of
example 2 except that the temperature of the shaking bath was
maintained at 40.degree. C.;
[0265] Resin 3A was prepared, using an above mentioned 200 gm resin
portion and a respective iodine sludge, following the procedures of
examples 2 to 4 except that for the procedure of example 3 the
elevated temperature and pressure conditions were set at
121.degree. C. and 15 psig respectively while the reaction time at
these elevated conditions was set at 1.5 hours rather than at 15
minutes; and
[0266] Resin 4B was prepared, using an above mentioned 200 gm resin
portion and a respective iodine sludge, following the procedure of
example 2 except that the reaction mixture was placed into a
container having a loose fitting cover; the container containing
the reaction mixture was placed into a heated water bath; the
temperature of the reaction mixture was brought up to a boiling
temperature of 100.degree. C. to 105.degree. C. over a period of 20
minutes and was maintained at the boiling temperature og
100.degree. C. to 105.degree. C. for a period of 15 minutes; and
thereafter the mixture was allowed to cool to room temperature over
a period of about 1 hour (the reactor was not a pressure sealed
reactor but one wherein the loose fitting cover allowed gas/vapour
to escape such that the reaction was carried out (essentially) at
atmospheric pressure--extra safety precautions had to be taken due
to the violent sputtering of the reaction mixture and to the
toxicity of the released gas/vapour). The density of each of the
obtained iodinated resins was determined in accordance with the
procedure outlined in example 5.1. The iodine content of the above
iodinated resins was determined in accordance with the procedure
outlined in example 5.3. The resins were also subjected to an
iodine bleed test as outlined in example 7. The results are shown
in table 14 below:
16 TABLE 14 Resin type Iodine % Iodine leach Density Resin 1A 46.4
0.5 ppm 1.616 gm.backslash.ml Resin 2B 48.1 1.5 ppm 1.694
gm.backslash.ml Resin 3A 45.0 0.5 ppm 1.661 gm.backslash.ml Resin
4B 45.7 1.0 ppm 1.595 gm.backslash.ml
[0267] As may be seen from table 14, subjecting the starting
iodine/resin mixture to a treatment at essentially atmospheric
pressure and a temperature of 100.degree. C. to 105.degree. C. or
lower (resin 2B and 4B) does not result in the iodine being as
tenaciously fixed to the resin as when using both a temperature
above 100.degree. C. and a pressure above atmospheric pressure
(resins 1A and 3A).
EXAMPLE 15
[0268] Sterilisation barrier combinations for use as wound
(sterilisation) dressings
EXAMPLE 15.1
[0269] Preparation of sterilisation foam dressing
[0270] The following starting materials were used to prepare a
sterilisation foam dressing:
[0271] a particulate iodinated resin prepared in accordance with
example 9 above; the resin comprising particles or beads of about
0.3 mm to about 0.7 mm;
[0272] R/O water; and
[0273] as foam precursor, HYPOL foamable hydrophilic polyurethane
polymer, (code : # FHP2002) from W. R. Grace & Co., Organic
Chemicals Division, Lexington, Mass. 02173.
[0274] The sterilisation foam barrier was prepared as follows:
[0275] 150 ml of R/O water was placed into a 300 ml beaker. The
water was heated to 50.degree. C. 10 cc of the HYPOL and 10 gm of
the iodinated resin were simultaneously admixed with the heated
water; mixing was accomplished with a magnetic stirring rod and was
carried out before and after the addition of the HYPOL and the
resin for the purpose of dispersing the resin particles as
homogeneously as possible throughout the mixture. The obtained foam
was set or cured in about 7 minutes; the resin particles were
dispersed throughout the matrix of the foam which was of porous
cellular structure (i.e. sponge like). Once set the obtained
flexible foam had a semi-sphere like form (see for example FIG. 9);
slices of this foam material were taken so as to provide a foam
dressing having an essentially flat face for being applied against
a wound. The obtained sterilisation foam was flexible and sponge
like in that it could absorb liquids such as water, pus and the
like.
EXAMPLE 15.2
[0276] Preparation of a band-aid like sterilisation dressing
[0277] The following starting materials were used to prepare a
band-aid sterilisation dressing:
[0278] a particulate iodinated resin prepared in accordance with
example 4 above; the resin comprising particles or beads of about
0.3 mm to about 0.7 mm; and
[0279] a strip of polymeric material having an adhesive on one face
thereof (the strip was Compeed).
[0280] The sterilisation strip barrier was prepared as follows:
[0281] An open ended ring funnel was disposed over a central area
of the strip on the adhesive face thereof. Resin beads were placed
in the stem of the ring funnel so as to essentialy cover the
central portion of the adhesive face defined by the ring; a plunger
was shoved into the ring and a mild pressure was applied to the
resin beads therein. The ring was removed along with excess resin
beads so as to leave behind a single layer of resin beads fixed to
the adhesive face of the strip; the resin beads in the layer
essentialy abutted each other. The strip barrier had a form as
shown in FIG. 8; if desired the beads do not have to abut but could
be spaced apart.
EXAMPLE 15.3
[0282] Animal infection study: cuts
[0283] The foam type sterilisation dressing obtained from example
15.1 was tested as follows:
[0284] Eight male guinea pigs were shaved so as to expose
essentially the same skin area. The guinea pigs each weighed about
500 to 550 gm and were obtained from Charles River, Quebec, Canada,
a sub-division of Bausch & Lomb; the guinea pigs were
quarantined for a period of 48 hours before being prepared for and
subjected to the tests.
[0285] The guinea pigs were prepared for the tests as follows:
[0286] Essentially the same area of skin of each of the guinea pigs
was anesthetised using Carbocaine-V (chlorhydrate of Mepivacaine
USP 2%); this anesthetic has no known sterilisation qualities. An
inoculum comprising a mixture of Staphillococus Aureus and
Pseudomonas Aeriginosa was prepared at 109 cfu/ml; the ratio of
Staphillococus Aureus to Pseudomonas Aeriginosa was 1:1. 0.2 ml of
the inoculum was injected under the anesthetised skin of each
animal. A cruciform structured scalpel cut (#) was made above the
inoculum injection area of each of the animals; i.e. the cuts were
1.0 to 4.0 cm long and 1.0 to 4.0 mm deep. Additional inoculum was
dabbed onto the surface cuts.
[0287] The animals were divided into two groups of four animals
each, one group to be used as a control group and the other group
as a test group. A foam sterilisation dressing was applied over the
wound for each of the animals of the test group, i.e. the foam
dressing was placed in contact with the wounded skin area and
maintained in place during the period of the test. The foam
dressings were maintained in place over the wound area by means of
an adhesive strip which was provided with an opening or window by
means of which a portion of the foam dressing was left uncovered
and exposed to the air. No dressing or sterilisation material was
applied to the wounds of the animals of the control group.
[0288] The four animals of the test group with dressings developed
no infection and the scaring process was initiated after 16 hours.
On the other hand the four control animals developed infection and
the infection was still spreading after 72 hours.
[0289] The strip type sterilisation dressing obtained from example
15.2 was tested exactly as above for the foam dressing with exactly
the same results.
EXAMPLE 15.4
[0290] Animal infection study: burns
[0291] The same studies as described in example 15.3 were carried
out except that the lesion was a burn created with a 1.0 cm red hot
rod; the hot rod was firmly held against the skin for about 3 to 4
seconds. The same Inoculum as in example 15.3 was injected beneath
the burn area and also dabbed onto the surface of the burned skin.
Exactly the same results were obtained for the two types of
dressings as were obtained for the tests of example 15.3.
EXAMPLE 15.5
[0292] Animal infection study: cuts with continual contact with
infectious liquid
[0293] The foam type sterilisation dressing obtained from example
15.1 was tested as follows:
[0294] Four male guinea pigs were shaved so as to expose
essentially the same skin area. The guinea pigs each weighed about
500 to 550 gm and were obtained from Charles River, Quebec, Canada;
the guinea pigs were quarantined for a period of 48 hours before
being prepared for and subjected to the tests.
[0295] The guinea pigs were prepared for the tests as follows:
[0296] Essentially the same area of skin of each of the guinea pigs
was anesthetised using Carbocaine-V (chlorhydrate of Mepivacaine
USP 2%); the area was also sterilised using 70% isopropyl alcohol.
A cruciform structured scalpel cut (#) was then made in the
sterilised area; i.e. the cuts were 1.0 to 4.0 cm long and 1.0 to
4.0 mm deep.
[0297] The animals were divided into two groups of two animals
each, one group to be used as a control group and the other group
as a test group. A foam sterilisation dressing was applied over the
wound for each of the animals of the test group, i.e. the foam
dressing was placed in contact with the wounded skin area and
maintained in place during the period of the test. The foam
dressings were maintained in place over the wound area by means of
an adhesive strip which was provided with an opening or window by
means of which a portion of the foam dressing was left uncovered
and exposed. No dressing or sterilisation material was applied to
the wounds of the animals of the control group.
[0298] An inoculum comprising a mixture of Stanhillococus Aureus
and Pseudomonas Aeriginosa was prepared at 10.sup.7 cfu/100 ml; the
ratio of Staphillococus Aureus to Pseudomonas Aericinosa was 1:1.
Sufficient inoculum was prepared such that each of the animals of
the test and control group could be bathed in the inoculum such
that the bath liquid was in continual contact with the wound area,
i.e. the bath liquid covered the dressings. The animals of each
group were kept in the bath inoculum for a period of 72 hours.
[0299] The two animals of the test group with dressings developed
no infection and the scaring process was in full process. On the
other hand the two control animals each had developed
infection.
EXAMPLE 15.6
[0300] Animal infection study: cuts contacted with aerosol borne
infectious agents
[0301] The same procedure as for example 15.5 was used except that
instead of being maintained in a bath of inoculum, the inoculum was
applied using an atomiser the same as that used for example 11.2
for artificial creation of airborne infection of a wound; the
inoculum used also had 10.sup.9 cfu/ml rather than 10.sup.7 cfu/100
ml as in example 15.6. 4 ml of the inoculum was sprayed directly on
the wound of the control animals and on the dressing covering the
wound of the test animals; the inoculum was so applied every hour
for 8 hours with 72 hours of incubation. The same results as in
example 15.5 were obtained.
EXAMPLE 15.7
[0302] Skin reaction study: iodine tincture
[0303] Three male guinea pigs were shaved so as to expose
essentially the same skin area. The guinea pigs each weighed about
500 to 550 gm and were obtained from Charles River, Quebec, Canada;
the guinea pigs were quarantined for a period of 48 hours before
being prepared for and subjected to the tests.
[0304] The guinea pigs were prepared for the tests as follows:
[0305] Essentially the same area of skin of each of the guinea pigs
was anesthetised using Carbocaine-V (chlorhydrate of Mepivacaine
USP 2%); the area was also sterilised using &0& isopropyl
alcohol. A cruciform structured scalpel cut (#) was made in the
sterilised area; i.e. the cuts were 1.0 to 4.0 cm long and 1.0 to
4.0 mm deep.
[0306] An inoculum comprising a mixture of Staphillococus Aureus
and Pseudomonas Aeriginosa was prepared at 10.sup.9 cfu/ml; the
ratio of Stanhillococus Aureus to Pseudomonas Aeriginosa was
1:1.
[0307] The inoculum was only dabbed onto the surface of the wounds
of each of the animals (no injection of inoculum under the skin).
It was found that a 5% iodine tincture locally applied on the
wounds would neutralise infection provided that the iodine tincture
was applied at 0.1 ml directly after infection and every 2 hours
thereafter for 10 hours; the iodine tincture was from Jean Coutu,
Quebec, Canada--5% iodine, 3.3% KI and 75% ethanol. However, it was
noted that the skin in the periphery of the wound was seriously
devitalised because of the burning effect of the tincture i.e. of
the iodine.
[0308] It was also found that the iodine tincture did not stop
infection from occurring if inoculum was injected under the
skin.
EXAMPLE 15.8
[0309] Skin reaction study: sterilisation dressings
[0310] Three male guinea pigs were shaved so as to expose
essentially the same skin area. The guinea pigs each weighed about
500 to 550 gm and were obtained from Charles River, Quebec, Canada;
the guinea pigs were quarantined for a period of 48 hours before
being subjected to the tests.
[0311] A foam sterilisation dressing of example 15.1 was applied
over a shave skin area-of each of the animals, i.e. the foam
dressing was placed in contact with the shaved skin area and
maintained in place during the period of the test. The foam
dressings were maintained in place over the skin area by means of
an adhesive strip which was provided with an opening or window by
means of which a portion of the foam dressing was left uncovered
and exposed to the air. The dressing was maintained in place for a
period of 3 weeks. The covered skin area was examined every two
days. No redness, rash, inflammation, or any other reaction was
noted; the covered skin remained healthy.
[0312] The above procedure was also carried out using a strip
sterilisation dressing of example 15.2. However the dressing was
maintained in place only for 7 days. Again, no redness, rash,
inflammation, or any other reaction was noted; the covered skin
remained healthy.
[0313] FIGS. 7 to 11 illustrate a number of example embodiements of
sterilisation barrier combinations of the present invention; some
of these combinations are also described in example 15 above. FIG.
7 shows a partially cut away perspective view of a sterilisation
barrier dressing of tea-bag type construction wherein the iodinated
resin particles or beads (one of which is designated by the
reference numeral 30) are free flowing but are held together by
being enveloped by a fluid (e.g air-liquid) permeable envelope 31
of (known) pharmaceutically acceptable paper or gauze (e.g. a
suitable sterile gauze from Johnson & Johnson, Canada). The
paper or gauze is permeable to fluids such as air and water but is
able to hold onto the particles of iodinated resin enveloped
thereby since any holes in the paper gauze are sized to be smaller
than the particles of resin. This type of dressing may be made
relatively small or relatively large keeping in mind the size of
the lesion that it is intended to cover. The dressing may be made
by providing a sheet of paper or gauze, placing the desired amount
of resin particles thereon and then folding one side edge of the
paper or gauze over the resin particles 30 so as to overlay and
abut the opposite side; these abuting side edges 32 and 33 as well
as each of the respective side edges of the two pairs of adjacent
side edges indicated generally at 34 and 35 may be fixed together
in any known manner, for example by compression, stitching or by
the use of any known phamaceutically acceptable adhesive. The
fixation of the sides is such that they will tend to maintain their
integrity in the face of water , body fluids or body exudates (e.g.
pus). The embodiment shown in FIG. 7 is shown may be considered as
essentially having a plurality of resin bead layers; it could of
course have only a single such layer.
[0314] Alternatively, the sterilisation barrier may take on a
band-aid type aspect as shown in FIG. 8. The combination shown has
a flexible carrier component 36. A central portion of one side of
the carrier component 36 has fixed thereto a plurality of beads or
particles (one of which is designated by the reference numeral 37)
of demand disinfectant iodinated resin. The resin beads 37 are
fixed to the surface by a suitable adhesive which is
pharmacetically acceptable and which will maintain the beads on the
carrier component even if exposed to water or body fluids or
exudates. The portion of the band surface 38 which surrounds the
centrally disposed beads 36 may also be provided with any (known)
adhesive which may for example be able to releasably stick the
combination to the skin (e.g. a latex based adhesive). The carrier
component 36 may, as desired be permeable or impermeable to fluids
such as air, water, pus; prefereably, the carrier is permeable to
gas such as air, water vapour, etc. at least in the region of the
resin beads fixed thereto, i.e. this region is air breathable. The
carrier component 36 may be of any suitable pharmaceutically
acceptable (plastics) material (e.g. the carrier component may be a
porous hydrophobic material permeable to air and water vapour such
as described in U.S. Pat. Nos. 3,953,566 and 4,194,041--Gore-Tex).
The carrier component complete with an adhesive face may be
obtained from Peco Marketing ltd., Montreal, Quebec under the name
"Compeed".
[0315] FIGS. 9, 10 and 11 show a number of further embodiments of
the sterilisation barrier combination.
[0316] FIG. 9 shows a flexible sterilisation foam or sponge type
dressing 39 for wounds. The dressing comprises a flexible
pharmaceutically acceptable foam matrix 40 having iodinated resin
particles (one of which is designated with the reference numeral
41) dispersed therein. The foam matrix 40 has a porous open cell
structure such that it is permeable to fluids such as air and water
and can absorb body liquids in the manner of a sponge (e.g. the
foam is hydrophilic and/or oil loving); the foam barrier is air
breathable. The foam matrix 40 as shown has cells of relatively
small size so as to facilitate the absorption of liquids such as
pus. The resin particles 41 making up the resin disinfectant
component are distributed throughout and held or fixed in place by
the polymeric matrix 40 such that surface portions of the resin
particles are exposed within the cells of the matrix 40. The
exposed surfaces of the resin are available for contact with any
microorganisms which may find their way into the cells of the body
of the barrier combination; contact with the resin devitalises the
microorganisms.
[0317] The foam sterilisation barrier or dressing 39 as shown in
FIG. 9 has a semi-spherical like shape. The flat surface 42 may be
applied to a wound or cut. The dressing may be held in place by any
suitable means such as for example any suitable strapping or by
adhesive tape means. Preferably, the sterilisation foam dressing 39
is held in place such that at least a portion of it is exposed
(e.g. exposed to the air); thus the means for holding the foam in
place may be an adhesive strip which has a central opening exposing
at least a portion of the foam when the foam is held in place. Once
in place on the wound, the flexible foam sterilisation barrier will
sterilise the immediate area of the wound which it covers and also
prevent other infectious microorganisms from contacting the wound
from outside the body. Surprisingly, however, it has been found
that the sterilisation barrier is also effective not only against
microorganisms at the immediate surface of a wound but also against
those deeper within the body in the area of a cut.
[0318] FIG. 10 illustrates another type of flexible foam
sterilisation barrier 43. It differs from the sterilisation barrier
shown in FIG. 9 in that the size of the cells (one of which is
designated with the reference numeral 44) is significantly larger
than those for the foam shown in FIG. 9; this type of foam may be
used as a liner material for wearing apparel to provide the apparel
with the ability to protect the wearer from (skin) contact with
viable microorganisms. The resin beads, spheres or particles (one
of which is designated with the reference numeral 45) are, as in
the case of the resin spheres 41 for the foam barrier 39 of FIG. 9,
dispersed in the foam matrix and are held or fixed in place thereby
such that exposed surfaces of the resin are available for contact
with any microorganisms which may find their way into the cells of
the body of the barrier combination; contact with the resin
devitalises the microorganisms.
[0319] The foam matrix for the sterilisation barriers of FIGS. 9
and 10 may be made by admixing (known) starting reactants in
(known) manner to make (known) foams which are pharmaceutically
acceptable. Known polyurethane foams may for example be used. In
order to make the sterilisation barrier, the disinfectant resin
particles may be admixed with and dispersed (e.g. more or less
homogeneously) in the starting reactants at the beginning of the
foam producing reaction. The foam barrier may be set in molds or
else cut to the desired shape. The foam sterilisation barrier may
take any desired form such as sheets, films, plugs, and the like;
it may, for example, be molded so as to conform to the shape of
portion of the body to which it is to be applied.
[0320] As mentioned above a (flexible) phamaceutically acceptable
hydrophilic foam matrix may be obtained using water and HYPOL
foamable hydrophilic polyurethane polymer starting material from W.
R. Grace & Co. Lexintington Mass. U.S.A.
[0321] The pore or cell size of the foam barrier may be adjusted in
known manner; for example by altering the reaction temperature. For
example in the case of HYPOL a temperature of about 50 to
70.degree. C. may be used to obtain small pore sizes and a lower
temperature of about 35 to 45.degree. C. may be used to obtainer
larger sized pores.
[0322] FIG. 11 shows a cross sectional portion of a sandwich type
textile material 46 which incorporates a flexible large cell size
sterilisation foam layer 47. The sandwich comprises two outer
flexible clothe type layers 48 and 49 which are fixed to the
central sterilisation foam barrier 46 in any suitable manner (e.g.
by an adhesive, melt fusion, etc.). The two outer layers 48 and 49
may be of any desired material; they may be permeable or
impermeable to fluids such as air, water vapour, water and the
like. They may for example be of cotton, polypropylene, etc.; or a
Gore-tex type material mentioned above. A sheet of textile material
as shown may cut into pieces of various shapes needed to form such
protective wearing apparel as may be desired, e.g. coats, pants,
socks, face masks (e.g. full face masks or masks covering only the
mouth and nose) and the like.
[0323] The flexible foam layer 47 can be made in any known manner
provided that disinfectant resin particles are dispersed in the
reaction mixture during the reaction such that the end product foam
also has the resin particles dispersed in the foam matrix and any
microorganism able to penetrate into an interior cell of the foam
may be able to contact a resin particle exposed into the cell and
be devitalised thereby. The foam barrier as in the case of the foam
dressings mentioned may be configured to be permeable to fluids
such as air, water, etc . . .
[0324] The textile material 46 may be formed by first forming a
sheet of the sterilisation foam; by providing sheets of the desired
outer layers; and then gluing the elements together such that the
foam is sandwiched between the two other outer layers.
Alternatively, a mold may be used wherein opposed surfaces of the
mold are provided with a respective outer layer; the foam starting
materials are introduced between the layers; and foaming activated
such that the foam layer is produced in situ.
[0325] Although shown with two outer layers the combination of FIG.
11 may of course have only one such clothe like layer. Additionally
if the outer layer or layers are permeable to fluids such as air,
water, pus and the like, the wearing apparel made therefrom could
as needed double as a kind of sterilisation dressing; the textile
may thus for example be air breathable.
[0326] Additionally although the foam sterilisation barrier has
been described in relation to a flexible foam it may be a stiff
foam depending upon the application; again the stiff foam matrix
may be prepared in known manner.
[0327] An alternate embodiement of the sandwich type textile may be
made wherein the foam matrix is omitted; in this case the beads may
be placed between the outer layers and the beads may be fixed in
place for example by an adhesive or by melt fusion depending on the
nature of the layers (e.g. melt fusion may be considered if the
layers are of thermoplastics material; the textile may of course be
so made as to preserve the flexibility of the combination.
* * * * *